Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lung Cancer,2017,NCI,1U01CA199240-01A1,,Detroit Research on Cancer Survivors (Detroit ROCS),"SCHWARTZ, ANN",WAYNE STATE UNIVERSITY,MI,"$1,666,685"
Lung Cancer,2017,NCI,5R01CA169102-05,,Personalized Motion Management for truly 4D Lung Stereotactic Body Radiotherapy,"SAWANT, AMIT",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$605,037"
Lung Cancer,2017,NCI,5U01CA194393-03,,Quantifying and Characterizing the shared genetic contribution to common cancers,"LINDSTROEM, SARA",UNIVERSITY OF WASHINGTON,WA,"$566,464"
Lung Cancer,2017,NCI,5R21CA197912-02,,Challenges to effective implementation of lung cancer screening,"SONEJI, SAMIR",DARTMOUTH COLLEGE,NH,"$176,175"
Lung Cancer,2017,OD,1R56CA198492-01A1,,Integrated Nano-Therapeutics to Overcome Tumor Plasticity and Resistance,"AMIJI, MANSOOR",NORTHEASTERN UNIVERSITY,MA,"$299,852"
Lung Cancer,2017,NCI,5R01CA184173-03,,A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments,"REN, LEI",DUKE UNIVERSITY,NC,"$363,342"
Lung Cancer,2017,NIEHS,5R01ES005775-23,,"Hypoxia, DNA repair, and gene silencing","GLAZER, PETER",YALE UNIVERSITY,CT,"$374,625"
Lung Cancer,2017,NCI,5R01CA191489-03,,A novel lineage pathway controls metabolic adaptation by metastatic lung cancers,"NGUYEN, DON",YALE UNIVERSITY,CT,"$380,278"
Lung Cancer,2017,NCI,5R21CA202487-02,,KRAS Muations in Plasma cfDNA as Predictor to Erolinib Response in Advanced Pancreatic Cancer,"LI, DONGHUI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Lung Cancer,2017,NIEHS,5R01ES020868-04,,Molecular Mechanism of Arsenic Carcinogenesis,"JIANG, BINGHUA",THOMAS JEFFERSON UNIVERSITY,PA,"$329,418"
Lung Cancer,2017,NCI,5R01CA172229-05,,AMPK and AMPK-related kinases in lung cancer development and treatment,"SHAW, REUBEN",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$402,550"
Lung Cancer,2017,NCI,5R21CA201856-03,,Prevention of genomic instability by a scavenger of bifunctional electrophiles,"OATES, JOHN",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$203,975"
Lung Cancer,2017,NCI,5F31CA189772-03,,Deciphering vimentin phosphorylation in cancer cell invasion and metastasis,"SALGUEIRO, ALESSANDRA",EMORY UNIVERSITY,GA,"$44,044"
Lung Cancer,2017,NCI,5R21CA202993-02,,A Novel Worksite Smoking Cessation intervention for Hispanic Construction Workers,"LEE, DAVID",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$166,931"
Lung Cancer,2017,NCI,5R01CA195227-02,,Lead optimization of novel ML-IAP antagonists to treat lung cancer,"COSFORD, NICHOLAS",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$974,339"
Lung Cancer,2017,NCI,5R01CA187392-02,,Tumor-associated neutrophils in human lung cancer,"ERUSLANOV, EVGENIY",UNIVERSITY OF PENNSYLVANIA,PA,"$366,000"
Lung Cancer,2017,NCI,5R03CA202354-02,,Genomic markers predicting tumor response to cytotoxic chemotherapy,"DEMANT, PETER",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$85,750"
Lung Cancer,2017,NCI,5R01CA201049-02,,Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M,"ECK, MICHAEL",DANA-FARBER CANCER INST,MA,"$425,882"
Lung Cancer,2017,NCI,5R21CA195110-02,,Novel Protein Risk Markers for Lung Cancer,"PERERA, FREDERICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$184,217"
Lung Cancer,2017,NCI,5R01CA200999-03,,"Sex Hormones, Phytoestrogens and Lung Cancer in Female Nonsmokers","YANG, GONG",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$342,888"
Lung Cancer,2017,NIMHD,4R00MD010468-03,,Applying mHealth to Tobacco-related Health Disparities: Enhancing aspects of Resiliency to aid Cessation Efforts,"VINCI, CHRISTINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$248,937"
Lung Cancer,2017,NCI,5R01CA124495-10,,Identification and targeting of the signaling pathways underlying lung cancer.,"KISSIL, JOSEPH",SCRIPPS FLORIDA,FL,"$432,000"
Lung Cancer,2017,NCI,5R21CA192950-02,,Improving Pediatric Tobacco Control in Primary Care,"TERCYAK, KENNETH",GEORGETOWN UNIVERSITY,DC,"$169,533"
Lung Cancer,2017,NCI,5R01CA193583-02,,Estrogen Signaling in a Mouse Model for Lymphangioleiomyomatosis,"HAMMES, STEPHEN",UNIVERSITY OF ROCHESTER,NY,"$351,608"
Lung Cancer,2017,NCI,5R01CA194027-02,,Developing a pharmacologic approach to treat LKB1 mutant NSCLC patients,"MARCUS, ADAM",EMORY UNIVERSITY,GA,"$504,281"
Lung Cancer,2017,NCI,5R01CA136534-07,,Structure-based anti-cancer drug development,"DENG, XINGMING",EMORY UNIVERSITY,GA,"$370,500"
Lung Cancer,2017,NCI,5R01CA175691-04,,Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL,"TESTA, JOSEPH",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$556,046"
Lung Cancer,2017,NCI,5R01CA184510-03,,Genetic analysis of ras mutation specificity in skin and lung cancer,"BALMAIN, ALLAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,512"
Lung Cancer,2017,NIGMS,5R01GM103790-02,,Receptor and Carriers for Coupled Ion Transport,"SESSLER, JONATHAN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$300,186"
Lung Cancer,2017,NCI,5R01CA091021-14,,"Tobacco Companies, Public Policy and Global Health","LEE, KELLEY",SIMON FRASER UNIVERSITY,CANADA,"$515,442"
Lung Cancer,2017,NCATS,1R13TR001693-01,,5th International Symposium on Non-neuronal Acetylcholine: From Bench to Bedside,"GRANDO, SERGEI",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$20,000"
Lung Cancer,2017,NCI,5R21CA202529-02,,Develop and Apply a Novel Genome-wide Mendelian Randomization Method to Examine Relationship between Obesity and Lung Cancer,"WANG, TAO","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$208,405"
Lung Cancer,2017,NCI,5U01CA190234-03,,Genotype and Imaging Phenotype Biomarkers in Lung Cancer,"AERTS, HUGO",DANA-FARBER CANCER INST,MA,"$667,641"
Lung Cancer,2017,NCI,5R01CA201340-02,,Defining Early Escape Strategies in LKB1 Mutant Lung Cancer,"MARCUS, ADAM",EMORY UNIVERSITY,GA,"$369,821"
Lung Cancer,2017,NCI,7R01CA191222-02,,Therapeutic efficacy of the CRL inhibitor MLN4924 in NF2 mutant mesothelioma,"GIANCOTTI, FILIPPO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$510,996"
Lung Cancer,2017,NCI,5R01CA162226-05,,Eicosanoids in Lung Cancer: Progression and Metastasis,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$322,663"
Lung Cancer,2017,NCI,5R01CA200900-02,,Systemic RNA Delivery to Tumors,"SHI, JINJUN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$547,422"
Lung Cancer,2017,NCI,5R01CA193556-02,,Near infrared intraoperative molecular imaging of lung adenocarcinoma,"SINGHAL, SUNIL",UNIVERSITY OF PENNSYLVANIA,PA,"$674,649"
Lung Cancer,2017,NCI,5P30CA014236-43,5327,Cancer Control and Population Sciences Research Program,"KASTAN, MICHAEL",DUKE UNIVERSITY,NC,"$26,669"
Lung Cancer,2017,NCI,5R03CA201951-02,,Time to first cigarette and early detection in the National Lung Screening Trial,"MUSCAT, JOSHUA",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$77,350"
Lung Cancer,2017,NCI,5R01CA166119-05,,Consistent anatomy registration for lung cancer adaptive radiation therapy,"HUGO, GEOFFREY",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$306,493"
Lung Cancer,2017,NCI,5R01CA172660-05,,The Role of p53-inducible Sesn1 and Sesn2 genes in lung carcinogenesis,"GROSSMAN, STEVEN",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$316,438"
Lung Cancer,2017,NIEHS,5R01ES016893-10,,Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts,"WISE, JOHN",UNIVERSITY OF LOUISVILLE,KY,"$344,748"
Lung Cancer,2017,NIBIB,5R01EB020366-03,,Next generation 4D-CBCT for lung cancer radiation therapy,"WANG, JING",UT SOUTHWESTERN MEDICAL CENTER,TX,"$364,500"
Lung Cancer,2017,NCI,5R21CA191711-02,,Couple-based meditation program for patients with metastatic lung cancer and their partners,"MILBURY, KATHRIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$208,800"
Lung Cancer,2017,NHLBI,5K08HL130666-03,,The role of the long non-coding RNA Falcor in early endoderm and lung development,"SWARR, DANIEL",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$162,540"
Lung Cancer,2017,NCI,5R01CA200817-02,,Clinical trial personalizing radiation therapy through a novel lung function imaging modality,"VINOGRADSKIY, YEVGENIY",UNIVERSITY OF COLORADO DENVER,CO,"$237,451"
Lung Cancer,2017,NCI,5R01CA047135-27,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$636,410"
Lung Cancer,2017,NHLBI,5R01HL121267-04,,Mutant Surfactant - Induced TGF-beta Secretion in Lung Fibrosis,"GARCIA, CHRISTINE",UT SOUTHWESTERN MEDICAL CENTER,TX,"$459,473"
Lung Cancer,2017,NCI,5P30CA023108-38,5366,Cancer Control (CC),"SARGENT, JAMES",DARTMOUTH COLLEGE,NH,"$74,804"
Lung Cancer,2017,NCI,5P30CA008748-51,7574,Biostatistic,"GONEN, MITHAT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$903,482"
Lung Cancer,2017,NCI,7R01CA167516-05,,HuR Targeted Nanotherapy for Lung Cancer,"RAMESH, RAJAGOPAL",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$342,194"
Lung Cancer,2017,NCI,5R01CA172560-05,,Mechanisms of action of the Smyd3 methyltransferase in cancer cells,"GOZANI, OR",STANFORD UNIVERSITY,CA,"$457,506"
Lung Cancer,2017,NCI,5R01CA181360-04,,Clustered semi-competing risks analysis in quality of end-of-life care studies,"HANEUSE, SEBASTIEN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$446,179"
Lung Cancer,2017,NCI,5R01CA166054-05,,Effect of anti-S phase agents on human chromosomes,"DUTTA, ANINDYA",UNIVERSITY OF VIRGINIA,VA,"$327,850"
Lung Cancer,2017,NCI,5K07CA180782-04,,The Cost-Effectiveness of Lung Cancer Screening in HIV Infection,"SIGEL, KEITH",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$136,080"
Lung Cancer,2017,NCI,5R01CA197422-02,,Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up,"ZABLOTSKA, LYDIA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$680,242"
Lung Cancer,2017,NCI,5UM1CA173642-05,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,260,718"
Lung Cancer,2017,NCI,5R01CA169338-05,,Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment,"BIVONA, TREVER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$342,701"
Lung Cancer,2017,NCI,2P30CA046934-29,5076,"Lung, Head & Neck Cancers Program","THEODORESCU, DAN",UNIVERSITY OF COLORADO DENVER,CO,"$52,680"
Lung Cancer,2017,NCI,5R01CA081301-19,,Metabolism of Carcinogenic Tobacco-Specific Nitrosamines,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA,MN,"$508,571"
Lung Cancer,2017,NCI,2P30CA006516-52,5407,Program 13: Cancer Risk and Disparities,"VISWANATH, KASISOMAYAJULA",DANA-FARBER CANCER INST,MA,"$41,323"
Lung Cancer,2017,NCI,2P30CA006516-52,5411,Program 34: Lung Cancer,"JOHNSON, BRUCE",DANA-FARBER CANCER INST,MA,"$39,659"
Lung Cancer,2017,NCI,1P01CA210944-01,5575,Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients,"VONDERHEIDE, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$654,726"
Lung Cancer,2017,NIGMS,1P20GM121288-01,6065,Project 3-Human papillomavirus in HIV associated lung cancers,"LIN, ZHEN",TULANE UNIVERSITY OF LOUISIANA,LA,"$284,262"
Lung Cancer,2017,NCI,2P30CA012197-42,6114,Clinical Research (03),"PASCHE, BORIS",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$49,492"
Lung Cancer,2017,NCI,2P30CA012197-42,6115,Cancer Prevention and Control (04),"PASCHE, BORIS",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$43,670"
Lung Cancer,2017,NCI,5R35CA197605-02,,Mucins and immune cell interactions in ovarian cancer pathogenesis & progression,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,031,346"
Lung Cancer,2017,NCI,1R01CA211052-01,,Optimizing biologically-based rational polytherapy in ALK+ lung cancer,"BIVONA, TREVER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,569"
Lung Cancer,2017,NIEHS,5R01ES022935-04,,SATB2 and Nickel Carcingenesis,"COSTA, MAX",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$455,228"
Lung Cancer,2017,NIEHS,5R01ES025515-03,,"Oxidative stress, Cr(VI) carcinogenesis, and prevention","SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$338,625"
Lung Cancer,2017,NCI,5R01CA174786-04,,Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers,"CHEN, JING",EMORY UNIVERSITY,GA,"$325,412"
Lung Cancer,2017,NCI,5R01CA175316-04,,Transcription-dependent and -independent signaling of RSK2 in cancer metastasis,"KANG, SUMIN",EMORY UNIVERSITY,GA,"$323,700"
Lung Cancer,2017,NCI,5R01CA183594-04,,Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect,"CHEN, JING",EMORY UNIVERSITY,GA,"$325,093"
Lung Cancer,2017,NCI,1R01CA211125-01,,Regulation of lung cancer metastasis through transcriptional control of the Golgi apparatus,"KURIE, JONATHAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$378,946"
Lung Cancer,2017,NCI,5R44CA174037-03,,Chemical Optimization of a novel class of USP7 inhibitor for cancer treatment,"WEINSTOCK, JOSEPH","PROGENRA, INC.",PA,"$748,944"
Lung Cancer,2017,NINR,1R01NR016694-01,,Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer,"GREER, JOSEPH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$533,179"
Lung Cancer,2017,NCI,1R03CA211143-01,,Improving dose coverage of tumor periphery in radiotherapy of lung cancer through the use of flattening filter free beams,"VASSILIEV, OLEG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$80,000"
Lung Cancer,2017,NCI,5P30CA016520-41,7996,Biostatistics Core,"TROXEL, ANDREA",UNIVERSITY OF PENNSYLVANIA,PA,"$604,005"
Lung Cancer,2017,NCI,1UH2CA206126-01A1,,Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients,"WONG, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$184,223"
Lung Cancer,2017,NCI,5R01CA188341-03,,IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer,"HOUGHTON, A. MCGARRY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$396,219"
Lung Cancer,2017,NCI,5F30CA196103-03,,MicroRNAs mediating Notch signaling in lung adenocarcinoma,"MORGAN, KATHERINE",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$49,044"
Lung Cancer,2017,NCI,5R01CA185169-04,,Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics,"MCKNIGHT, STEVEN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$475,351"
Lung Cancer,2017,NCI,5R01CA121249-08,,Cachexia in ApcMin/+ mice: The role of IL-6,"CARSON, JAMES",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$296,663"
Lung Cancer,2017,NCI,1R03CA204825-01A1,,Weight cycling and total and site-specific cancer incidence and mortality,"GIOVANNUCCI, EDWARD",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$79,354"
Lung Cancer,2017,NCI,5R01CA175336-05,,Molecular Dissection of Lung Cancer Progression and Metastasis,"WINSLOW, MONTE",STANFORD UNIVERSITY,CA,"$331,185"
Lung Cancer,2017,NCI,5R01CA192613-03,,Pemetrexed and sildenafil for lung cancer,"DENT, PAUL",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$313,959"
Lung Cancer,2017,NCI,5R01CA178061-03,,Statistical Qualification of the Impact of Missing Data in EMA Studies,"XIE, HUI",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$286,577"
Lung Cancer,2017,NCI,1R01CA204004-01A1,,Use of Alternative Tobacco Products Among Homeless Youth,"TUCKER, JOAN",RAND CORPORATION,CA,"$404,103"
Lung Cancer,2017,NCI,5R01CA169603-05,,The Mechanisms of PKM2-Regulated Gene Expression in Tumor Development.,"LU, ZHIMIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Lung Cancer,2017,NCI,5R01CA088932-15,,Regulation of Telomerase by Sphingolipid Signaling in Lung Cancer,"OGRETMEN, BESIM",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$205,835"
Lung Cancer,2017,NCI,5R01CA163293-06,,Pulmonary Rehabiltation before Lung Cancer Resection,"BENZO, ROBERTO",MAYO CLINIC ROCHESTER,MN,"$268,352"
Lung Cancer,2017,NCI,5R01CA181449-03,,Interrogation of MLL2 as a tumor suppressor gene in lung cancer,"MACPHERSON, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$402,600"
Lung Cancer,2017,NCI,5R01CA169259-05,,Overcoming resistance to tyrosine kinase inhibitors in lung cancer,"KOBAYASHI, SUSUMU",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,$1
Lung Cancer,2017,NCI,1R01CA203636-01A1,,Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment,"NISHINO, MIZUKI",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$606,587"
Lung Cancer,2017,NCI,5R01CA175360-04,,The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer,"WU, JANE",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$442,925"
Lung Cancer,2017,NCI,5R01CA186729-03,,Differential regulation of RNA processing by Akt isoforms,"TSICHLIS, PHILIP",TUFTS MEDICAL CENTER,MA,"$377,438"
Lung Cancer,2017,NCI,5R01CA176568-04,,"Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes","WU, XIFENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$479,955"
Lung Cancer,2017,NCI,5R01CA193532-02,,Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy,"TESSEMA, MATHEWOS",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$535,737"
Lung Cancer,2017,NCI,5R01CA105155-13,,Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase,"KURIE, JONATHAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$291,471"
Lung Cancer,2017,NCI,5R01CA203193-02,,Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer,"WISNIVESKY, JUAN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$647,610"
Lung Cancer,2017,NCI,1R01CA204302-01A1,,Characterization of YAP as a rational companion target in lung cancer,"BIVONA, TREVER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,569"
Lung Cancer,2017,NCI,5F31CA203254-02,,Biochemical and Functional Characterization of the Mutagenic Cytidine Deaminase APOBEC3B in the contextof Squamous Cell Lung Carcinoma,"SASAKI, TOMOAKI",YALE UNIVERSITY,CT,"$44,044"
Lung Cancer,2017,NCI,5F31CA203488-02,,Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarcinoma,"AYENI, DEBORAH",YALE UNIVERSITY,CT,"$28,692"
Lung Cancer,2017,NCI,5P01CA163223-05,7601,Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cells: A systems biochemical approach,"FAN, TERESA",UNIVERSITY OF KENTUCKY,KY,"$251,655"
Lung Cancer,2017,NCI,5P01CA163223-05,7602,Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in,"YAN, JUN",UNIVERSITY OF KENTUCKY,KY,"$240,785"
Lung Cancer,2017,NCI,5P01CA163223-05,7603,Determining Molecular Mechanisms of NSCLC and Response to beta-glucan,"LANE, ANDREW",UNIVERSITY OF KENTUCKY,KY,"$236,598"
Lung Cancer,2017,NCI,5P01CA163223-05,7604,"Administration, Bioinformatics and Biostatistics Core","LANE, ANDREW",UNIVERSITY OF KENTUCKY,KY,"$125,308"
Lung Cancer,2017,NCI,5P01CA163223-05,7605,Stable Isotope Resolved Metabolomics Analytical Shared Core,"HIGASHI, RICHARD",UNIVERSITY OF KENTUCKY,KY,"$284,058"
Lung Cancer,2017,NCI,5R01CA166615-05,,Chemoprevention of inflammation-driven lung cancer,"KASSIE, FEKADU",UNIVERSITY OF MINNESOTA,MN,"$315,400"
Lung Cancer,2017,NCI,5R01CA173754-05,,Benefits and Harms of Lung Cancer Screening in HIV Infection,"CROTHERS, KRISTINA",UNIVERSITY OF WASHINGTON,WA,"$416,472"
Lung Cancer,2017,NCI,5R01CA193698-03,,Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy,"AVANTAGGIATI, MARIA",GEORGETOWN UNIVERSITY,DC,"$355,706"
Lung Cancer,2017,NCI,5R01CA197928-02,,Small-Molecule Antagonists of Ral GTPases in Cancer,"MEROUEH, SAMY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$590,913"
Lung Cancer,2017,NCI,1R01CA204173-01A1,,DNA damage signaling to immune checkpoints,"BAKKENIST, CHRISTOPHER",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$385,018"
Lung Cancer,2017,NCI,5R01CA203964-02,,Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics,"ZHANG, DAVID",RICE UNIVERSITY,TX,"$612,394"
Lung Cancer,2017,NCI,5R01CA204419-02,,Induction of Therapeutic Immunity in the Tumor Microenvironment,"STORKUS, WALTER",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$343,580"
Lung Cancer,2017,NCI,1R01CA203995-01A1,,THE ROLE OF POLYCOMB ASSOCIATED LONG NON-CODING RNAS IN LUNG CANCER METASTASIS,"MAHER, CHRISTOPHER",WASHINGTON UNIVERSITY,MO,"$348,844"
Lung Cancer,2017,NIEHS,1R01ES026657-01A1,,Microenvironment and Arsenic Lung Tumorigenesis,"CHEN, GANG",UNIVERSITY OF KENTUCKY,KY,"$344,250"
Lung Cancer,2017,NIEHS,3R01ES025515-03S1,,"Oxidative stress, Cr(VI) carcinogenesis, and prevention","SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$415,500"
Lung Cancer,2017,NCI,1R01CA200691-01A1,,Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India,"SORENSEN, GLORIAN",DANA-FARBER CANCER INST,MA,"$641,938"
Lung Cancer,2017,NCI,2R01CA166480-06,,MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer,"KUFE, DONALD",DANA-FARBER CANCER INST,MA,"$642,150"
Lung Cancer,2017,NCI,5U10CA180795-04,,Building upon a tradition of excellence. The NCTN at Indiana University,"MILLER, KATHY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$519,002"
Lung Cancer,2017,NCI,5U01CA177799-05,,Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations,"ZAMAN, MUHAMMAD",BOSTON UNIVERSITY (CHARLES RIVER CAMPUS),MA,"$571,427"
Lung Cancer,2017,NCI,5R01CA204020-02,,Role of GAS41 in human cancer,"SHI, XIAOBING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lung Cancer,2017,NCI,1R01CA200547-01A1,,Investigating CREBBP as a tumor suppressor in small cell lung cancer,"MACPHERSON, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$441,962"
Lung Cancer,2017,NCI,1R01CA204264-01A1,,A novel point of care test for oral and oropharyngeal cancer risk,"CALIFANO, JOSEPH",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$593,922"
Lung Cancer,2017,NCI,1R01CA207500-01A1,,Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS,"FRANGIONI, JOHN","CURADEL, LLC",MA,"$767,586"
Lung Cancer,2017,NCI,1R01CA200905-01A1,,Modulation of BAK in Lung Cancer Therapeutics,"DENG, XINGMING",EMORY UNIVERSITY,GA,"$356,850"
Lung Cancer,2017,NCI,1R01CA205426-01A1,,Elucidating genetics of response to immune checkpoint blockade in lung cancer,"RIZVI, NAIYER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$573,644"
Lung Cancer,2017,NCI,5U10CA180816-04,,Stanford University NCTN- Network Lead Academic Site,"WAKELEE, HEATHER",STANFORD UNIVERSITY,CA,"$547,394"
Lung Cancer,2017,NCI,5R01CA166703-05,,Predicting Pulmonary Function Change to Improve Radiation Planning and Outcome,"BAYOUTH, JOHN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$371,731"
Lung Cancer,2017,NCI,5U10CA180950-04,,ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center,"RAMALINGAM, SURESH",EMORY UNIVERSITY,GA,"$772,699"
Lung Cancer,2017,NCI,5R01CA195720-03,,Targeting the Immune System in Mouse Models of Lung Adenocarcinoma,"POLITI, KATERINA",YALE UNIVERSITY,CT,"$579,271"
Lung Cancer,2017,NIEHS,5R01ES014032-08,,Cancer in adults following in utero and early life exposure to arsenic,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$443,807"
Lung Cancer,2017,NCI,5R01CA197486-02,,Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer,"PATEL, ABHIJIT",YALE UNIVERSITY,CT,"$383,156"
Lung Cancer,2017,NIDCR,5R01DE026013-02,,Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$545,000"
Lung Cancer,2017,NCI,2U01CA167552-06,,Cancer Epidemiology Cohort in Male Health Professionals,"WILLETT, WALTER",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$1,884,447"
Lung Cancer,2017,NCI,1R01CA213293-01,,Protein Arginine Methylation in Chemotherapy Resistance,"XU, WEI",UNIVERSITY OF WISCONSIN-MADISON,WI,"$160,001"
Lung Cancer,2017,NCI,5R01CA177852-03,,"INHIBITION OF A TREG DEUBIQUITINASE, USP7, PROMOTES ANTI-TUMOR IMMUNITY","HANCOCK, WAYNE",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$380,640"
Lung Cancer,2017,NCI,1U24CA213274-01,,Coordinating center for the NCI small cell lung cancer research consortium,"RUDIN, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$1,184,296"
Lung Cancer,2017,NCI,5R01CA192399-03,,Identifying tumor suppressor targets of SIRT6 in lung cancer,"MAYO, MARTY",UNIVERSITY OF VIRGINIA,VA,"$384,919"
Lung Cancer,2017,NCI,5F31CA196035-03,,The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy,"GARRIS, CHRISTOPHER",HARVARD MEDICAL SCHOOL,MA,"$31,579"
Lung Cancer,2017,NCI,1U01CA213330-01,,Extracellular Vesicles in Small Cell Lung Cancer Early Detection,"NANA-SINKAM, SERGE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$613,368"
Lung Cancer,2017,NCI,1U01CA213333-01,,Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer,"WONG, KWOK KIN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$703,909"
Lung Cancer,2017,NCI,1U01CA213359-01,,Preclinical development of a DLL3-targeted theranostic for small cell lung cancer,"POIRIER, JOHN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$355,035"
Lung Cancer,2017,NCI,5R01CA167827-05,,Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of,"SUTER, MELISSA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$562,380"
Lung Cancer,2017,NCI,5UM1CA167462-05,,INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY,"GOODMAN, GARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$527,567"
Lung Cancer,2017,NCI,5K07CA197221-02,,Designing a Comprehensive Framework for the Evaluation of Tobacco Product Risks,"BERMAN, MICAH",OHIO STATE UNIVERSITY,OH,"$161,174"
Lung Cancer,2017,NIGMS,5R01GM100387-05,,Transfer Rule Learning with Functional Mapping for Integrative Modeling of Panomics Data,"GOPALAKRISHNAN, VANATHI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$288,978"
Lung Cancer,2017,NCI,5F31CA196037-02,,Understanding how graphic warnings on cigarette packs increase quit intentions,"HALL, MARISSA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$4,928"
Lung Cancer,2017,NCI,5R01CA163772-05,,Lung Adenocarcinoma Invasion Genomics,"POWELL, CHARLES",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$566,724"
Lung Cancer,2017,NCI,5R01CA174481-05,,Web-based Smoking Cessation Program for Tribal College Students,"CHOI, WON",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$556,175"
Lung Cancer,2017,NCI,5U10CA180868-04,,NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER,"WOLMARK, NORMAN","NRG ONCOLOGY FOUNDATION, INC.",PA,"$13,475,638"
Lung Cancer,2017,NCI,5R21CA204938-02,,Ect2 Function in Lung Adenocarcinoma Initiation and Maintenance,"JUSTILIEN, VERLINE",MAYO CLINIC  JACKSONVILLE,FL,"$182,909"
Lung Cancer,2017,NCI,1R01CA205420-01A1,,Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery,"KASINSKI, ANDREA",PURDUE UNIVERSITY,IN,"$349,399"
Lung Cancer,2017,NIEHS,5P42ES023720-04,7653,Biomedical Project 4 - Animal Models of Mesothelioma,"TESTA, JOSEPH",UNIVERSITY OF PENNSYLVANIA,PA,"$328,008"
Lung Cancer,2017,NIEHS,5P42ES023720-04,7654,Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases,"CHRISTOFIDOU-SOLOMIDOU, MELPO",UNIVERSITY OF PENNSYLVANIA,PA,"$283,038"
Lung Cancer,2017,NIEHS,5P42ES023720-04,7655,Biomedical Project 6 - Biomarkers of Asbestos Exposure,"BLAIR, IAN",UNIVERSITY OF PENNSYLVANIA,PA,"$279,569"
Lung Cancer,2017,NCI,5R01CA169470-05,,Hyperpolarized NMR for Studies of Cancer Therapies Targeting the Warburg Effect,"GRANT, AARON",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$361,050"
Lung Cancer,2017,NCI,5R01CA188743-03,,Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring,"LJUBIMOVA, JULIA",CEDARS-SINAI MEDICAL CENTER,CA,"$511,546"
Lung Cancer,2017,NCI,5R01CA081436-20,,Protein Kinase C Signaling Mechanisms in Cancer,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$391,250"
Lung Cancer,2017,NCI,5P30CA014599-42,5654,CANCER PREVENTION AND CONTROL,"LE BEAU, MICHELLE",UNIVERSITY OF CHICAGO,IL,"$24,515"
Lung Cancer,2017,NCI,5R01CA156744-07,,The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2,"SUN, YI",UNIVERSITY OF MICHIGAN,MI,"$368,125"
Lung Cancer,2017,NCI,5R01CA168761-05,,Chemical disruption of Wnt-mediated signal transduction,"KIM, JAMES",UT SOUTHWESTERN MEDICAL CENTER,TX,"$464,007"
Lung Cancer,2017,NCI,5U01CA186157-03,,Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection,"LAMPE, PAUL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$516,409"
Lung Cancer,2017,NCI,5R01CA190542-03,,RIP1/3 Kinases as New Targets in Malignant Mesothelioma,"TESTA, JOSEPH",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$435,685"
Lung Cancer,2017,NCI,5R01CA172253-05,,Dissemination and implementation of a corrective intervention to improve mediasti,"OSAROGIAGBON, RAYMOND",UNIVERSITY OF MEMPHIS,TN,"$480,200"
Lung Cancer,2017,NCI,5R01CA175086-05,,MutT Homolog 1 as a Novel Mediator of RAS Oncogene-Induced Pro-Malignant Pathways,"RAI, PRIYAMVADA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$318,513"
Lung Cancer,2017,NCI,5R01CA201513-02,,Notch signaling in small cell lung carcinoma,"SAGE, JULIEN",STANFORD UNIVERSITY,CA,"$371,618"
Lung Cancer,2017,NCI,5R21CA205746-02,,Immunological miRNA biomarkers for diagnosis of lung cancer,"JIANG, FENG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$168,019"
Lung Cancer,2017,NCI,5R01CA137008-08,,Impact of heterogeneity on response to EGFR T790M inhibitors,"SEQUIST, LECIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$406,220"
Lung Cancer,2017,NCI,5R21CA197493-02,,Macro-vasculature surrounding pulmonary nodules as a sign of malignancy,"PU, JIANTAO",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$202,439"
Lung Cancer,2017,NCI,5R01CA177996-04,,CYCORE: Cyberinfrastructure for Cancer Comparative Effectiveness Research,"PATRICK, KEVIN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$498,865"
Lung Cancer,2017,NCI,5P30CA077598-19,6561,Analytical Biochemistry,"YEE, DOUGLAS",UNIVERSITY OF MINNESOTA,MN,"$165,590"
Lung Cancer,2017,NCI,5P30CA077598-19,6562,(Basic Shared Resources) Analytical Biochemistry,"YEE, DOUGLAS",UNIVERSITY OF MINNESOTA,MN,"$120,989"
Lung Cancer,2017,NCI,5R03CA205713-02,,Allogeneic antibody therapy for malignant mesothelioma,"BURT, BRYAN",BAYLOR COLLEGE OF MEDICINE,TX,"$79,250"
Lung Cancer,2017,NCI,5U01CA200495-02,,"Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer","SHOWE, LOUISE",WISTAR INSTITUTE,PA,"$671,654"
Lung Cancer,2017,NCI,5R21CA205340-02,,Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer,"FELDSER, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$210,105"
Lung Cancer,2017,NCI,5R21CA198657-02,,Immunotoxins based on the IgG response to autologous antigens in cancer patients,"DESSAIN, SCOTT",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$225,309"
Lung Cancer,2017,NIDA,5R01DA035796-04,,Advancing Tobacco Use Treatment for African American Smokers,"COX, LISA",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$633,057"
Lung Cancer,2017,NCI,5R21CA193633-02,,Targeting RIP3-mediated Necroptosis for Chemosensitization,"LIN, YONG",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$237,075"
Lung Cancer,2017,NCI,5R21CA198327-02,,Modifier of Cancer Sensitivity to Statins,"MU, DAVID",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$191,183"
Lung Cancer,2017,NIMHD,5U01MD010648-02,,"Taxi STEP (Social networks, Technology, and Exercise through Pedometers)","GANY, FRANCESCA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$559,809"
Lung Cancer,2017,NCI,5P30CA086862-17,7673,Program 4: Cancer Epidemiology and Population Science,"LYNCH, CHARLES",UNIVERSITY OF IOWA,IA,"$25,763"
Lung Cancer,2017,NCI,5R01CA205150-02,,Therapeutic approaches for LKB1-deficient non-small cell lung cancer,"HEYMACH, JOHN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$605,252"
Lung Cancer,2017,NCI,1R01CA213448-01,,"Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody","POIRIER, JOHN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$446,668"
Lung Cancer,2017,NCI,5R21CA205414-02,,Validation of 4-miRNA signature for early lung cancer detection,"CHEN, GUOAN",UNIVERSITY OF MICHIGAN,MI,"$162,590"
Lung Cancer,2017,NCI,1R43CA213545-01,,A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS,"MORGAN, LEE","DEKK-TEC, INC.",LA,"$143,294"
Lung Cancer,2017,NCI,1R44CA206795-01A1,,"GC4419, an SOD Mimetic, as a Radiomodulator in Lung Cancer Patients Treated with SBRT","KEENE, JEFFERY","GALERA THERAPEUTICS, LLC",PA,"$224,736"
Lung Cancer,2017,NCI,1R43CA203142-01A1,,Aerosolized platinum nanoparticle chemotherapy for lung cancer,"GROER, CHAD","NANOPHARM, LLC",KS,"$298,065"
Lung Cancer,2017,NCI,1F32CA213764-01,,The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.,"MORRISON JOLY, MEGHAN",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$56,694"
Lung Cancer,2017,NCI,5R01CA184779-04,,An Olfactory Method for Controlling Cigarette Craving,"SAYETTE, MICHAEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$307,746"
Lung Cancer,2017,NCI,1F30CA213765-01,,Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma,"YOCHUM, ZACHARY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$49,044"
Lung Cancer,2017,NCI,1R01CA207375-01A1,,"The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care","FARJAH, FARHOOD",UNIVERSITY OF WASHINGTON,WA,"$609,467"
Lung Cancer,2017,NHLBI,5R01HL131907-02,,PET Imaging of Pulmonary Fibrosis,"CARAVAN, PETER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$752,477"
Lung Cancer,2017,NCI,1F32CA213898-01,,KLF6: A driving factor of lung adenocarcinoma,"MCKENNA, BRIAN",UNIVERSITY OF VIRGINIA,VA,"$58,766"
Lung Cancer,2017,NCI,1F32CA206247-01A1,,A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers,"WAGNER, ALEX",WASHINGTON UNIVERSITY,MO,"$59,166"
Lung Cancer,2017,NCI,1F30CA214015-01,,Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer,"NNADI, CHIMNO","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,548"
Lung Cancer,2017,NCI,5R01CA077026-18,,Visual Media Influences on Adolescent Smoking Behavior,"SARGENT, JAMES",DARTMOUTH COLLEGE,NH,"$521,341"
Lung Cancer,2017,NCI,5F32CA196000-04,,Defining the contributions by macrophages in BRAFV600E induced lung tumorigenesis,"PRINGLE, DAPHNE",UNIVERSITY OF UTAH,UT,"$59,166"
Lung Cancer,2017,NCI,1R01CA208403-01A1,,A model for predicting response to PD-1 inhibitors in NSCLC,"GARON, EDWARD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$639,083"
Lung Cancer,2017,NIEHS,2P42ES004705-29,5068,Project 1: Exposomics and Arsenic Epidemiology,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$228,151"
Lung Cancer,2017,NIEHS,2P42ES004705-29,5071,Project 4: Using Adductomic Signatures to Evaluate Risks of Superfund Chemicals,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$312,061"
Lung Cancer,2017,NCI,5R33CA202822-02,,Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine,"SOKER, SHAY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$385,924"
Lung Cancer,2017,NCI,5R01CA204620-02,,Molecular Dissection of an Arntl2 induced pro-metastatic secretome,"WINSLOW, MONTE",STANFORD UNIVERSITY,CA,"$367,019"
Lung Cancer,2017,NCI,5R01CA206028-02,,(PQ9) Mitigation of chemotherapy induced peripheral neuropathy,"GEWIRTZ, DAVID",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$342,964"
Lung Cancer,2017,NCI,5P30CA016087-37,6479,ENVIRONMENTAL AND MOLECULAR CARCINOGENESIS,"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$27,088"
Lung Cancer,2017,NCI,5P30CA016087-37,6480,EPIDEMIOLOGY AND CANCER CONTROL,"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$27,088"
Lung Cancer,2017,NCI,5P30CA016087-37,6501,PLANNING AND EVALUATION,"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$51,793"
Lung Cancer,2017,NCI,5U24CA115091-12,,"University of Maryland, Baltimore Biomarker Reference Laboratory","STASS, SANFORD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$456,438"
Lung Cancer,2017,NIEHS,5R01ES021771-04,,Apoptosis resistance and Cr(VI) carcinogenesis,"ZHANG, ZHUO",UNIVERSITY OF KENTUCKY,KY,"$338,625"
Lung Cancer,2017,NCI,5R01CA182506-04,,Sirt2 Directs Kras IR Cell Resistance and Tumorigenesis,"VASILOPOULOS, ATHANASIOS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Lung Cancer,2017,NCI,5R01CA206155-02,,Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$403,382"
Lung Cancer,2017,NCI,5R01CA190722-03,,Targeting Anaphase Catastrophe to Combat Lung Cancer,"DMITROVSKY, ETHAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,425"
Lung Cancer,2017,NCI,5R33CA202867-02,,High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing,"NAGRATH, SUNITHA",UNIVERSITY OF MICHIGAN,MI,"$332,977"
Lung Cancer,2017,NCI,5R01CA193473-02,,Integrative systems approach to identify local oncogenic modulation of the IL12 axis,"KLINKE, DAVID",WEST VIRGINIA UNIVERSITY,WV,"$343,125"
Lung Cancer,2017,NCI,5R01CA185020-04,,(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$325,181"
Lung Cancer,2017,NCI,5R01CA190610-03,,Detoxication of Air Pollutants in Humans with a Broccoli Supplement,"GROOPMAN, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$421,934"
Lung Cancer,2017,NHLBI,2R01HL111190-05,,REGULATION OF LUNG DEVELOPMENT BY FGF9 SIGNALING PATHWAYS,"ORNITZ, DAVID",WASHINGTON UNIVERSITY,MO,"$469,259"
Lung Cancer,2017,NCI,5R01CA130893-10,,Role of Autophagy in Cancer,"WHITE, EILEEN","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$311,976"
Lung Cancer,2017,NCI,5R01CA197329-03,,Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$540,936"
Lung Cancer,2017,NCI,5R21CA205430-02,,PQ3: Age-related immune deviation and cancer outcome,"MAECKER, HOLDEN",STANFORD UNIVERSITY,CA,"$206,190"
Lung Cancer,2017,NIDA,2R01DA027232-05A1,,Effect of sex differences and concurrent cannabis use on stress-related psychobiological mechanisms associated with smoking cessation and relapse,"AL'ABSI, MUSTAFA",UNIVERSITY OF MINNESOTA,MN,"$397,279"
Lung Cancer,2017,NCI,5R01CA190394-03,,Targeting the cytokine circuitry of KRAS-driven lung cancer,"BARBIE, DAVID",DANA-FARBER CANCER INST,MA,"$394,578"
Lung Cancer,2017,NCI,5R01CA197936-02,,Determinants of acquired resistance in small cell lung cancer,"RUDIN, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$619,653"
Lung Cancer,2017,NCI,5R21CA191425-02,,Msi2 regulates the aggressiveness of Non-Small Cell Lung Cancer (NSCLC),"GOLEMIS, ERICA",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$232,943"
Lung Cancer,2017,NCI,5R35CA197452-03,,Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma,"FLORES, ELSA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$904,402"
Lung Cancer,2017,NCI,5R33CA202811-02,,Development and Validation of a Microdissection Method to Advance Precision Medicine in the Clinical Setting,"JOHANN, DONALD",UNIV OF ARKANSAS FOR MED SCIS,AR,"$385,890"
Lung Cancer,2017,NHLBI,5R01HL105397-07,,Genetic Association and Personalized Medicine,"PAN, WEI",UNIVERSITY OF MINNESOTA,MN,"$371,290"
Lung Cancer,2017,NCI,5R01CA172090-05,,PDLIM2 as a cancer and chemosensitizing target,"XIAO, GUTIAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$319,550"
Lung Cancer,2017,NCI,5R01CA184624-04,,elF4E-Dependent Translation Control in the Oncogenic Stress Response and Cancer,"RUGGERO, DAVIDE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$366,826"
Lung Cancer,2017,NCI,5R01CA195493-03,,Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer,"MORRIS, EVAN",YALE UNIVERSITY,CT,"$255,891"
Lung Cancer,2017,NCI,5R01CA148805-07,,Role of STE20 protein kinases in malignant mesothelioma,"CHERNOFF, JONATHAN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$434,625"
Lung Cancer,2017,NCI,5U01CA152662-07,,Validation of Biomarkers of Risk for the Early Detection of Lung Cancer,"MASSION, PIERRE",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$970,519"
Lung Cancer,2017,NIEHS,5R01ES024050-04,,Recognition of Environmental Carcinogen-DNA lesions by NER Proteins,"GEACINTOV, NICHOLAS",NEW YORK UNIVERSITY,NY,"$353,326"
Lung Cancer,2017,NCI,5R01CA193264-03,,ERK3 Kinase Signaling in Lung Cancer,"LONG, WEIWEN",WRIGHT STATE UNIVERSITY,OH,"$338,550"
Lung Cancer,2017,NCI,5R44CA192498-03,,Multi Source E-Beam kV X-Ray Tube for Image-Guided Radiotheraphy,"BOYD, DOUGLAS","TELESECURITY SCIENCES, INC.",NV,"$745,074"
Lung Cancer,2017,NCI,5U01CA194733-02,,Incorporating Biomarkers to Improve Lung Cancer Risk Prediction,"FENG, ZIDING",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$656,359"
Lung Cancer,2017,NCI,5K24CA201543-02,,Development of New Cancer Treatments and Investigators,"GERBER, DAVID",UT SOUTHWESTERN MEDICAL CENTER,TX,"$167,279"
Lung Cancer,2017,NCI,5K99CA197672-02,,Manipulating hTERT splicing in lung cancer cells.,"LUDLOW, ANDREW",UT SOUTHWESTERN MEDICAL CENTER,TX,"$144,720"
Lung Cancer,2017,NCI,5R01CA166348-05,,Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer,"TRAN, PHUOC",JOHNS HOPKINS UNIVERSITY,MD,"$335,670"
Lung Cancer,2017,NCI,5R01CA102792-15,,Use of Beta-lapachone for Lung Cancer Chemotherapy,"BOOTHMAN, DAVID",UT SOUTHWESTERN MEDICAL CENTER,TX,"$335,140"
Lung Cancer,2017,NCI,5R01CA169134-05,,HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition,"AMARAVADI, RAVI",UNIVERSITY OF PENNSYLVANIA,PA,"$312,942"
Lung Cancer,2017,NCI,5R01CA195549-03,,Novel target for therapy refractory lung tumors,"PENDERGAST, ANN MARIE",DUKE UNIVERSITY,NC,"$359,887"
Lung Cancer,2017,NCI,5R01CA173687-05,,Mechanisms of sphingolipid analogue drug FTY720-mediated NSCLC tumor suppression,"OGRETMEN, BESIM",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$310,213"
Lung Cancer,2017,NCI,5R01CA194461-03,,(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression,"PARK, KWON-SIK",UNIVERSITY OF VIRGINIA,VA,"$334,552"
Lung Cancer,2017,NCI,5R01CA194470-03,,(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors,"JANES, KEVIN",UNIVERSITY OF VIRGINIA,VA,"$446,627"
Lung Cancer,2017,NCI,5R01CA181537-04,,Metabolic regulation of cellular junction proteins,"WU, XU",MASSACHUSETTS GENERAL HOSPITAL,MA,"$352,307"
Lung Cancer,2017,NCI,5R01CA192849-03,,Randomized Trial of an Innovative Smartphone Intervention for Smoking Cessation,"BRICKER, JONATHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$596,895"
Lung Cancer,2017,NIGMS,5R01GM114204-03,,Nanopore single-molecule dielectrophoresis and biomedical detection,"GU, LI-QUN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$291,344"
Lung Cancer,2017,NCI,5R01CA193278-04,,Dihydromethysticin (DHM) for Lung Cancer Chemoprevention,"XING, CHENGGUO",UNIVERSITY OF FLORIDA,FL,"$316,616"
Lung Cancer,2017,NCI,5K07CA188142-03,,Evaluating a Risk Prediction Model for Lung Cancer,"SAKODA, LORI",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$192,744"
Lung Cancer,2017,NCI,5R01CA198121-02,,Dose-distribution radiomics to predict morbidity risk in radiotherapy,"DEASY, JOSEPH",SLOAN-KETTERING INST CAN RESEARCH,NY,"$577,764"
Lung Cancer,2017,NCI,5R21CA206309-02,,"(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS","HARRIS, REUBEN",UNIVERSITY OF MINNESOTA,MN,"$182,192"
Lung Cancer,2017,NCI,5R01CA204070-02,,"Lung cancer in never smokers: incidence, risk factors, and molecular characteristics in Asian American, Native Hawaiian and Pacific Islander females","GOMEZ, SCARLETT",CANCER PREVENTION INSTIT OF CALIFORNIA,CA,"$572,056"
Lung Cancer,2017,NCI,5R01CA187457-04,,Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer,"OLIVER, TRUDY",UNIVERSITY OF UTAH,UT,"$309,175"
Lung Cancer,2017,NIEHS,5R21ES026782-02,,Role of the endogenous gasotransmitter H2S in ETS-mediated airway disease,"GAROFALO, ROBERTO",UNIVERSITY OF TEXAS MED BR GALVESTON,TX,"$193,750"
Lung Cancer,2017,NIEHS,1R01ES027793-01,,Promoting Smoke-free Homes in Lakota Communities.,"HENDERSON, PATRICIA",BLACK HILLS CTR/AMERICAN INDIAN HEALTH,SD,"$153,803"
Lung Cancer,2017,NIGMS,1R01ES027793-01,,Promoting Smoke-free Homes in Lakota Communities.,"HENDERSON, PATRICIA",BLACK HILLS CTR/AMERICAN INDIAN HEALTH,SD,"$320,000"
Lung Cancer,2017,NCI,5F30CA206339-02,,EGFR rearrangements as oncogenic drivers and therapeutic targets in lung cancer,"GALLANT, JEAN-NICOLAS",VANDERBILT UNIVERSITY,TN,"$44,044"
Lung Cancer,2017,NCI,5R01CA174768-04,,Understanding optimal delivery systems for cancer care,"MILLER, DAVID",UNIVERSITY OF MICHIGAN,MI,"$377,699"
Lung Cancer,2017,NIEHS,5R01ES026845-02,,"Nrf2, autophagy, and arsenic carcinogenesis","ZHANG, DONNA",UNIVERSITY OF ARIZONA,AZ,"$339,634"
Lung Cancer,2017,NCI,5P30CA023100-31,6334,Cancer Prevention,"LIPPMAN, SCOTT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$20,683"
Lung Cancer,2017,OD,1S10OD021745-01A1,,Acquisition of Hyperpolarized Gas System for Lung MR Imaging,"ROYSTON, THOMAS",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$479,745"
Lung Cancer,2017,NCI,5F31CA206346-02,,Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer,"CRISTEA, SANDRA",STANFORD UNIVERSITY,CA,"$44,044"
Lung Cancer,2017,NCI,5R01CA157996-07,,METABOLIC REGULATORS OF TUMOR CELL GROWTH,"DEBERARDINIS, RALPH",UT SOUTHWESTERN MEDICAL CENTER,TX,"$158,634"
Lung Cancer,2017,NCI,5R01CA166327-05,,Regulation of Tumor Metabolism by Retinoblastoma Protein,"CLEM, BRIAN",UNIVERSITY OF LOUISVILLE,KY,"$311,250"
Lung Cancer,2017,NCI,5R01CA188298-03,,Noninvasive monitoring of lung cancer patients treated with radiotherapy,"DIEHN, MAXIMILIAN",STANFORD UNIVERSITY,CA,"$367,095"
Lung Cancer,2017,NCI,5R01CA193935-02,,The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer.,"DOEBELE, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$428,571"
Lung Cancer,2017,NIEHS,5R01ES026023-03,,Protein kinase C and lung carcinogenesis,"KAZANIETZ, MARCELO",UNIVERSITY OF PENNSYLVANIA,PA,"$391,197"
Lung Cancer,2017,NCI,5F30CA189793-04,,Design and Development of a Small Molecule-controlled Activator of RAS,"ROSE, JOHN",UNIVERSITY OF WASHINGTON,WA,"$43,144"
Lung Cancer,2017,NCI,5F30CA189339-04,,The Role of Nup88 Overexpression in Cellular Transformation and Tumorigenesis,"NAYLOR, RYAN",MAYO CLINIC ROCHESTER,MN,"$42,744"
Lung Cancer,2017,NCI,2P30CA016059-36,7936,Cancer Prevention and Control,"BRUNZELL, DARLENE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$61,722"
Lung Cancer,2017,NIEHS,5R01ES025460-03,,The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk,"LAZARUS, PHILIP",WASHINGTON STATE UNIVERSITY,WA,"$626,582"
Lung Cancer,2017,NCI,2P30CA006973-54,8087,Cancer Prevention and Control Program - 05,"RODEN, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$36,868"
Lung Cancer,2017,NCI,2P30CA069533-19,8177,Cancer Prevention & Control,"WINTERS-STONE, KERRI",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$47,389"
Lung Cancer,2017,NCI,5R01CA195740-03,,Credentialing Mouse Models for Immune System Therapy Research,"PEROU, CHARLES",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$581,304"
Lung Cancer,2017,NCI,2P01CA154303-06,8503,Project 1: Development of pharmacologic strategies to degrade mutant EGFR.,"JANNE, PASI",DANA-FARBER CANCER INST,MA,"$287,962"
Lung Cancer,2017,NCI,2P01CA154303-06,8504,Project 2: Identification of combination therapy for KRAS-driven lung cancers.,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$288,552"
Lung Cancer,2017,NCI,2P01CA154303-06,8505,Project 3: Targeting transcriptional mechanisms of therapeutic resistance in non-small cell lung cancer.,"HAMMERMAN, PETER",DANA-FARBER CANCER INST,MA,"$348,207"
Lung Cancer,2017,NCI,2P01CA154303-06,8506,Core A: Medicinal Chemistry,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$290,608"
Lung Cancer,2017,NCI,2P01CA154303-06,8507,Core B: Structure and Biochemistry,"ECK, MICHAEL",DANA-FARBER CANCER INST,MA,"$240,508"
Lung Cancer,2017,NCI,2P01CA154303-06,8508,Core C: Animal Modeling and Preclinical Therapeutics,"WONG, KWOK KIN",DANA-FARBER CANCER INST,MA,"$263,825"
Lung Cancer,2017,NCI,2P01CA154303-06,8509,Core D: Program Administration,"MEYERSON, MATTHEW",DANA-FARBER CANCER INST,MA,"$126,586"
Lung Cancer,2017,NIGMS,2SC1CA182843-05,,Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk,"SHANKER, ANIL",MEHARRY MEDICAL COLLEGE,TN,"$327,375"
Lung Cancer,2017,NCI,2P30CA138292-09,8759,Cancer Prevention and Control,"LASH, TIMOTHY",EMORY UNIVERSITY,GA,"$50,360"
Lung Cancer,2017,NCI,1U19CA203654-01A1,5122,Genomic predictors of smoking and lung cancer risk,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,NH,"$932,433"
Lung Cancer,2017,NCI,1U19CA203654-01A1,5123,Biomarkers of lung cancer risk,"BRENNAN, PAUL",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$741,584"
Lung Cancer,2017,NCI,1U19CA203654-01A1,5124,Translating Molecular and Clinical Data to Population Lung Cancer Risk Assessment,"HUNG, RAYJEAN",SINAI HEALTH SYSTEM,CANADA,"$517,070"
Lung Cancer,2017,NCI,1U19CA203654-01A1,5125,Administrative Core,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,NH,"$275,485"
Lung Cancer,2017,NCI,1U19CA203654-01A1,5126,Core B: Biostatistics Core,"LIN, XIHONG",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$367,134"
Lung Cancer,2017,NCI,5R21CA198824-02,,"Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit","TRAVERS, MAANSI",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$189,334"
Lung Cancer,2017,NCI,5R01CA204301-02,,Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratio,"BOWEN, STEPHEN",UNIVERSITY OF WASHINGTON,WA,"$461,368"
Lung Cancer,2017,NCI,5R01CA198117-03,,The role of IWS1 in development and tumorigenesis,"TSICHLIS, PHILIP",TUFTS MEDICAL CENTER,MA,"$531,687"
Lung Cancer,2017,NCI,5R01CA207216-02,,"Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs","SHIH, YA-CHEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$273,604"
Lung Cancer,2017,NCI,2R44CA188154-02,,Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research,"PREMSRIRUT, PREM","MIRIMUS, INC.",NY,"$656,563"
Lung Cancer,2017,NIBIB,5R01EB022558-02,,Targeting Solid Tumors Using Nano-Engineered MSCs,"PRABHA, SWAYAM",UNIVERSITY OF MINNESOTA,MN,"$329,006"
Lung Cancer,2017,NCI,5K07CA178331-05,,GENE-NEIGHBORHOOD INTERACTION IN ADOLESCENT AND YOUNG ADULT SMOKING,"LIAN, MIN",WASHINGTON UNIVERSITY,MO,"$132,216"
Lung Cancer,2017,NCI,5K08CA172354-05,,Characterization of lung cancer radiosensitizers from genome-wide RNAi screens,"KOZONO, DAVID",DANA-FARBER CANCER INST,MA,"$177,120"
Lung Cancer,2017,NCI,5R01CA175003-05,,Activating Bax as a therapeutic strategy for lung cancer,"LI, CHI",UNIVERSITY OF LOUISVILLE,KY,"$309,952"
Lung Cancer,2017,NCI,5F31CA192623-03,,EGFR T790M-mediated drug resistance in non-small cell lung cancer,"ESER, PINAR",HARVARD MEDICAL SCHOOL,MA,"$31,649"
Lung Cancer,2017,NCI,5R01CA200893-02,,INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY,"HELD, JASON",WASHINGTON UNIVERSITY,MO,"$348,844"
Lung Cancer,2017,NCI,5K24CA197382-03,,Examining Delivery of Integrated Tobacco Treatment in Cancer Care,"PARK, ELYSE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$173,064"
Lung Cancer,2017,NCI,5R01CA172921-05,,Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer,"ALBELDA, STEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$357,673"
Lung Cancer,2017,NCI,5R01CA193602-03,,p53-Mediated Tumor Immune Surveillance,"FELDSER, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$366,000"
Lung Cancer,2017,NCCIH,5K01AT007559-05,,Couple-Based Mind-Body Program for Lung Cancer Patients and their Partners,"MILBURY, KATHRIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$130,008"
Lung Cancer,2017,NCI,5R01CA182746-04,,GENOMIC HARBINGERS OF BRAIN METASTASIS IN NON SMALL CELL LUNG CANCER,"WATSON, MARK",WASHINGTON UNIVERSITY,MO,"$316,438"
Lung Cancer,2017,NCI,5R25CA203650-02,,Transdisciplinary Research in Energetics and Cancer (TREC) Training Grant,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$279,293"
Lung Cancer,2017,NCI,5R01CA067850-16,,Impact of Retail Tobacco Advertising on Youth Smoking,"HENRIKSEN, LISA",STANFORD UNIVERSITY,CA,"$316,000"
Lung Cancer,2017,NIDCR,5K23DE023572-05,,"Tobacco carcinogens as markers of exposure, carcinogenesis and risk in oral cance","KHARIWALA, SAMIR",UNIVERSITY OF MINNESOTA,MN,"$136,269"
Lung Cancer,2017,NCI,1K99CA215244-01,,Investigating the role of KLF5 genomic alterations in tumorigenesis,"ZHANG, XIAOYANG",DANA-FARBER CANCER INST,MA,"$133,606"
Lung Cancer,2017,NCI,1K99CA215249-01,,Mapping druggable co-dependency pathways in NRF2-driven lung cancers,"BAR-PELED, LIRON",SCRIPPS RESEARCH INSTITUTE,CA,"$114,750"
Lung Cancer,2017,NCI,5R01CA198138-03,,Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection,"CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$352,275"
Lung Cancer,2017,NCI,5R01CA183296-04,,Histone Methyltransferases as a Target for Lung Cancer Prevention,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$778,686"
Lung Cancer,2017,NCI,5R01CA193050-03,,A new imaging approach to radiotherapy planning for lung cancer,"RIZI, RAHIM",UNIVERSITY OF PENNSYLVANIA,PA,"$535,497"
Lung Cancer,2017,NCI,5P30CA043703-27,5473,TISSUE RESOURCES CORE FACILITY,"GERSON, STANTON",CASE WESTERN RESERVE UNIVERSITY,OH,"$151,408"
Lung Cancer,2017,NCI,5R35CA197568-03,,How do genome alterations cause human lung cancer?,"MEYERSON, MATTHEW",DANA-FARBER CANCER INST,MA,"$1,027,500"
Lung Cancer,2017,NCI,5R01CA178456-06,,Roles of PTPN11 in regulating and driving epithelial cancer,"WU, JIE",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$307,100"
Lung Cancer,2017,NIBIB,5U01EB012493-08,,Point-of care Microfluidics for Early Detection of Cancer,"TONER, MEHMET",MASSACHUSETTS GENERAL HOSPITAL,MA,"$2,082,080"
Lung Cancer,2017,NCI,5R01CA077263-18,,Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm,"MCDAID, HAYLEY","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$417,500"
Lung Cancer,2017,NCI,5R01CA135257-10,,Drug Resistance in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INST,MA,"$352,007"
Lung Cancer,2017,NCI,5K07CA172294-06,,Unraveling Genetic Determinants of Lung Cancer Risk in African Americans,"ALDRICH, MELINDA",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$160,123"
Lung Cancer,2017,NCI,1R01CA209818-01A1,,Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer,"MINKO, TAMARA","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$470,010"
Lung Cancer,2017,NCI,5F30CA180249-05,,Microvesicles and exosomes as a cancer biomarker detected with designed peptides,"KASTELOWITZ-LIEBERMAN, NOAH",UNIVERSITY OF COLORADO,CO,"$40,644"
Lung Cancer,2017,NCI,5U01CA186150-03,,"Blood Biomarkers for Lung Cancer Screening Risk Assessment, and Early Detection","TAGUCHI, AYUMU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lung Cancer,2017,NCI,1R03CA215372-01,,"THE EPIGENETIC ROLE OF THE NOVEL LONG NONCODING RNA, LCAL5, IN LUNG CANCER","WHITE, NICOLE",WASHINGTON UNIVERSITY,MO,"$76,250"
Lung Cancer,2017,NCI,5P01CA134294-10,7462,Statistical Methods for Analysis of Next Generation Sequencing Data in Gen,"LIN, XIHONG",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$140,235"
Lung Cancer,2017,NCI,5R01CA181184-04,,Regulation of Lung Cancer Metastasis by ZEB1,"KURIE, JONATHAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$331,805"
Lung Cancer,2017,NCI,5R21CA205589-02,,Defining the urban-rural continuum and distinguishing rural differences to prevent tobacco use,"STILLMAN, FRANCES",NATIONAL OPINION RESEARCH CENTER,IL,"$206,806"
Lung Cancer,2017,NCI,1R15CA208543-01A1,,Lung Cancer Screening: Identifying Factors Associated With Participation,"CARTER-HARRIS, LISA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$458,334"
Lung Cancer,2017,NCI,5R01CA087472-18,,Analysis of Tobacco Industry Documents,"GLANTZ, STANTON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$655,138"
Lung Cancer,2017,NCI,5U01CA166905-05,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$915,659"
Lung Cancer,2017,NCI,5R01CA206027-02,,PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing,"SIDRANSKY, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$652,278"
Lung Cancer,2017,NCI,5R01CA206367-02,,Therapeutic targeting of Kras-driven Lung Adenocarcinoma,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$357,994"
Lung Cancer,2017,NCI,1R03CA215777-01,,Engineered precancerous cells and tissues for discovery of lung cancer drivers,"PARK, KWON-SIK",UNIVERSITY OF VIRGINIA,VA,"$80,521"
Lung Cancer,2017,NCI,5R21CA199631-02,,Dissecting gastric cancer clonality with genomic analyses and patient xenografts,"CARVAJAL CARMONA, LUIS",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$204,885"
Lung Cancer,2017,NCI,5P30CA177558-05,8626,PROJECT 2. Planning and Evaluation,"EVERS, BERNARD",UNIVERSITY OF KENTUCKY,KY,"$109,787"
Lung Cancer,2017,NCI,5P30CA177558-05,8636,PROJECT 12. Protocal Review,"HAYSLIP, JOHN",UNIVERSITY OF KENTUCKY,KY,"$111,634"
Lung Cancer,2017,NCI,5R01CA196703-03,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",BOSTON CHILDREN'S HOSPITAL,MA,"$404,888"
Lung Cancer,2017,NCI,5R01CA201071-02,,Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy,"KAO, GARY",UNIVERSITY OF PENNSYLVANIA,PA,"$433,777"
Lung Cancer,2017,NCI,1U01CA215845-01,,Phenotype Transitions in Small Cell Lung Cancer,"QUARANTA, VITO",VANDERBILT UNIVERSITY,TN,"$511,899"
Lung Cancer,2017,NCI,5R01CA199137-03,,A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning,"AVIS, NANCY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$392,439"
Lung Cancer,2017,NCI,5R01CA172152-06,,Role of the SWI/SNF complex in tumor suppression,"ROBERTS, CHARLES",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$357,826"
Lung Cancer,2017,NCI,5R01CA207295-02,,Therapeutic strategies for targeting PARP1 in small cell lung cancer,"BYERS, LAUREN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lung Cancer,2017,NCI,5R01CA192954-04,,RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers,"SHUTER, JONATHAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$634,880"
Lung Cancer,2017,NCI,1R01CA205165-01A1,,Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung,"GALBIATI, FERRUCCIO",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$310,250"
Lung Cancer,2017,NCI,1R03CA215941-01,,"p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage","CHEON, HYEONJOO",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$79,250"
Lung Cancer,2017,NCI,1R03CA215947-01,,"Living with a Smoker, Cross-Domain Health Risk Behaviors, and Obesity","HOLAHAN, CAROLE","UNIVERSITY OF TEXAS, AUSTIN",TX,"$78,250"
Lung Cancer,2017,NCCIH,5U41AT008718-03,8282,MacMillan: Project 2; Technology and Research Development Project 2: FUSION (Macmillian),"MACMILLAN, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$316,745"
Lung Cancer,2017,OD,5U41AT008718-03,8282,MacMillan: Project 2; Technology and Research Development Project 2: FUSION (Macmillian),"MACMILLAN, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$105,582"
Lung Cancer,2017,NCCIH,5U41AT008718-03,8283,MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White),"WHITE, MICHAEL",UT SOUTHWESTERN MEDICAL CENTER,TX,"$47,334"
Lung Cancer,2017,OD,5U41AT008718-03,8283,MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White),"WHITE, MICHAEL",UT SOUTHWESTERN MEDICAL CENTER,TX,"$15,778"
Lung Cancer,2017,NCI,5R01CA172592-05,,Targeting RET in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INST,MA,"$541,784"
Lung Cancer,2017,NCI,5P30CA125123-11,8014,Cancer Prevention and Population Sciences Program (Project-006),"EL-SERAG, HASHEM",BAYLOR COLLEGE OF MEDICINE,TX,"$24,529"
Lung Cancer,2017,NCI,5F30CA200327-03,,Immunoediting in Human Cancer,"GEJMAN, RON",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$49,044"
Lung Cancer,2017,NCI,5R01CA136851-09,,Targeting ALK and ROS1 in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INST,MA,"$330,164"
Lung Cancer,2017,NCI,5R03CA202515-02,,Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for Chinese Taxi Drivers,"LENG, JENNIFER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$85,700"
Lung Cancer,2017,NCI,5R01CA207466-02,,Oral Microbiome and Lung Cancer Risk,"CAI, QIUYIN",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$731,073"
Lung Cancer,2017,NCI,1R01CA207098-01A1,,Role of the Histone Modifier KDM2A in Lung Cancer,"LEE, MIN GYU",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lung Cancer,2017,NINR,5R01NR015341-04,,Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice,"FERRELL, BETTY",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$606,580"
Lung Cancer,2017,NCI,5R01CA190740-03,,Molecular Mechanisms of Cachexia in Lung Cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$429,084"
Lung Cancer,2017,NCI,5R01CA196590-02,,Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$850,753"
Lung Cancer,2017,NCI,5P01CA059827-19,5909,Response-driven Treatment of Non-Small Cell Lung Cancer,"HAYMAN, JAMES",UNIVERSITY OF MICHIGAN,MI,"$284,672"
Lung Cancer,2017,NCI,5K07CA168883-05,,Telephone Symptom Management for Advanced Lung Cancer Patients and Caregivers,"MOSHER, CATHERINE",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$136,445"
Lung Cancer,2017,NCI,5U01CA188388-03,,Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy,"WONG, STEPHEN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$411,967"
Lung Cancer,2017,NCI,5R01CA188323-04,,Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN,MI,"$321,625"
Lung Cancer,2017,NHLBI,5R01HL116756-05,,Defining the role of Hippo signaling in airway injury repair and remodeling,"RAJAGOPAL, JAYARAJ",MASSACHUSETTS GENERAL HOSPITAL,MA,"$423,899"
Lung Cancer,2017,NCI,1R01CA204222-01A1,,Outcomes associated with significant incidental findings in lung cancer screening,"GAREEN, ILANA",BROWN UNIVERSITY,RI,"$345,401"
Lung Cancer,2017,NCI,5F32CA210427-02,,Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer,"HOLLERN, DANIEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$56,694"
Lung Cancer,2017,NCI,5R21CA209007-02,,ALK causes TGF-beta insensitivity in lung cancer cells,"FENG, XIN-HUA",BAYLOR COLLEGE OF MEDICINE,TX,"$206,843"
Lung Cancer,2017,NCI,5K07CA187071-04,,Evaluating the Effectiveness of Lung Cancer Screening in Patients with COPD,"KALE, MINAL",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$168,617"
Lung Cancer,2017,NCI,5R01CA210489-02,,"RPRD1B/Kub5/Hera, an RNA Pol II determinant that controls PARPi & IR sensitivity","BOOTHMAN, DAVID",UT SOUTHWESTERN MEDICAL CENTER,TX,"$370,575"
Lung Cancer,2017,NCI,5R01CA207133-02,,A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer,"WINSLOW, MONTE",STANFORD UNIVERSITY,CA,"$554,387"
Lung Cancer,2017,NCI,1R01CA207763-01A1,,The role of PCDH7 in lung cancer pathogenesis,"O'DONNELL, KATHRYN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$357,482"
Lung Cancer,2017,NCI,2R01CA139067-06,,miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$373,268"
Lung Cancer,2017,NCI,1R01CA207483-01A1,,Markerless Motion Tracking of Lung Tumors Using Dual Energy Imaging,"ROESKE, JOHN",LOYOLA UNIVERSITY CHICAGO,IL,"$385,045"
Lung Cancer,2017,NCI,1R01CA203928-01A1,,Targeted inhibition of ribosomal RNA synthesis in LKB1-deficient cancers,"ZHOU, WEI",EMORY UNIVERSITY,GA,"$356,850"
Lung Cancer,2017,NCI,2R01CA116020-11,,Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma,"ECK, MICHAEL",DANA-FARBER CANCER INST,MA,"$374,063"
Lung Cancer,2017,NIBIB,1R01EB022596-01A1,,Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation,"XIE, JIN",UNIVERSITY OF GEORGIA,GA,"$492,320"
Lung Cancer,2017,NCI,5R01CA141661-08,,Understanding Smokeless Tobacco and Electronic Cigarette Marketing,"LING, PAMELA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$550,559"
Lung Cancer,2017,NCI,5K99CA208028-02,,Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis,"CHOI, PETER",DANA-FARBER CANCER INST,MA,"$133,108"
Lung Cancer,2017,NIBIB,5R37EB000244-38,,Controlled Release of Macromolecules,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$390,000"
Lung Cancer,2017,NCI,5R21CA195317-02,,Assessing deformable image registration in the lung using hyperpolarized-gas MRI,"CAI, JING",DUKE UNIVERSITY,NC,"$172,765"
Lung Cancer,2017,NCI,5F30CA210444-02,,Dissecting the function of PI3K/mTOR pathway activation in ROS1 fusion-mediated oncogenesis and resistance to targeted therapy,"NEEL, DANA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,959"
Lung Cancer,2017,NCI,2R44CA171786-04,,Programmable Individualized NRT Merged With Digital Behavioral Support,"LEVY, ALAN","CHRONO THERAPEUTICS, INC.",CA,"$1,000,000"
Lung Cancer,2017,NCI,5K22CA197066-04,,Cancer-Health Disparities in Incarcerated Men,"VALERA, PAMELA",NATHAN S. KLINE INSTITUTE FOR PSYCH RES,NY,"$179,533"
Lung Cancer,2017,NCI,5R03CA202780-02,,"Sources and impact of stigma for rural breast, prostate and lung cancer survivors","THORBURN, SHERYL",OREGON STATE UNIVERSITY,OR,"$73,500"
Lung Cancer,2017,NCI,5R35CA197461-03,,Neuroscience-based Interventions for Cancer Risk Behavior Change,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$942,922"
Lung Cancer,2017,NCI,5F31CA210626-02,,The Role of the Hexosamine Biosynthetic Pathway in Non-Small Cell Lung Carcinoma,"RUIZ, CHRISTIAN",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$33,839"
Lung Cancer,2017,NCI,5K08CA191082-03,,Elucidating the regulation of mitosis by BRAF V600E in lung cancer,"LITO, PIRO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,036"
Lung Cancer,2017,NCI,5R21CA201707-02,,Oncogene Addiction Biomarkers for a KRAS Therapy,"POWIS, GARTH",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$212,063"
Lung Cancer,2017,NIDA,5R01DA036445-06,,A trial of Positively Smoke Free group therapy for HIV-infected smokers,"SHUTER, JONATHAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$662,003"
Lung Cancer,2017,NCI,5P30CA091842-16,6317,Cell-to-Cell Communications in Cancer (Project-006),"EBERLEIN, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$55,996"
Lung Cancer,2017,NCI,1R21CA208206-01A1,,Exposure to flavored tobacco advertising and associations with future use in young adults: implications for health equity,"ROSE, SHYANIKA",TRUTH INITIATIVE FOUNDATION,DC,"$168,483"
Lung Cancer,2017,NCI,5U01CA199216-03,,Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer,"JACKSON, PETER",STANFORD UNIVERSITY,CA,"$663,150"
Lung Cancer,2017,NCI,5F30CA189731-04,,Immunological function and potential role of microRNA as a novel cancer treatment,"HUFFAKER, THOMAS",UNIVERSITY OF UTAH,UT,"$49,044"
Lung Cancer,2017,NIGMS,5R01GM097478-07,,Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection,"DMOCHOWSKI, IVAN",UNIVERSITY OF PENNSYLVANIA,PA,"$362,040"
Lung Cancer,2017,NIEHS,1R21ES026996-01A1,,"Air Quality, Child, and Adult Health in Homes where Hookahs are Smoked","WEITZMAN, MICHAEL",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$211,875"
Lung Cancer,2017,NCI,5P30CA016086-41,8635,Cancer Prevention and Control Research Program (Program 8),"RIBISL, KURT",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$38,686"
Lung Cancer,2017,NCI,5R01CA201358-02,,Genome-wide Pleiotropy Scan across Multiple Cancers,"WITTE, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$648,968"
Lung Cancer,2017,NCI,5R35CA197573-03,,Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking,"FIORE, MICHAEL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$888,930"
Lung Cancer,2017,NCI,5R01CA197147-02,,"Phosphodiesterase 10A, a novel target for lung cancer chemoprevention","PIAZZA, GARY",UNIVERSITY OF SOUTH ALABAMA,AL,"$346,556"
Lung Cancer,2017,NCI,5R01CA197314-04,,Small Financial Incentives to Promote Smoking Cessation in Safety Net Hospital Patients,"KENDZOR, DARLA",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$303,797"
Lung Cancer,2017,NCI,5R44CA199920-03,,Tailored NRT Integrated with Smartphone Behavioral Support,"LEVY, ALAN","CHRONO THERAPEUTICS, INC.",CA,"$1,000,000"
Lung Cancer,2017,NCI,1R01CA208648-01A1,,Chemoprevention of lung cancer with mitochondria-targeted honokiol,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$620,971"
Lung Cancer,2017,NCI,1R21CA216650-01,,Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma,"LEE, MENQ-JER",WAYNE STATE UNIVERSITY,MI,"$179,988"
Lung Cancer,2017,NCI,5K07CA190706-03,,Impact of Specialist Palliative Care on Outcomes in Advanced Stage Lung Cancer,"SULLIVAN, DONALD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$165,234"
Lung Cancer,2017,NCI,5R01CA188446-04,,A high efficiency imager for real-time lung cancer monitoring during radiotherapy,"BERBECO, ROSS",DANA-FARBER CANCER INST,MA,"$768,460"
Lung Cancer,2017,NCI,2R01CA164273-06,,Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors,"SHAW, ALICE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$399,380"
Lung Cancer,2017,NCI,1R21CA209436-01A1,,Methylome characterization of bronchial epithelial projenitor cells,"SPIVACK, SIMON","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$216,172"
Lung Cancer,2017,NCI,5R01CA114536-12,,TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$458,731"
Lung Cancer,2017,NIDCR,5F30DE026048-02,,DNA damage activates non-canonical mTORC1 signaling through mammalian EAK-7 in HNSCC.,"NGUYEN, JOE",UNIVERSITY OF MICHIGAN,MI,"$49,844"
Lung Cancer,2017,NCI,5F30CA180607-04,,Characterization of AMH as part of a novel TGF-beta signaling loop,"BECK, TIM",DREXEL UNIVERSITY,PA,"$42,538"
Lung Cancer,2017,NCI,5R01CA190628-03,,Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing,"FANG, BINGLIANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$514,090"
Lung Cancer,2017,NCI,5F32CA210409-02,,Optimizing Immunotherapy Strategies to Eliminate Recurrences after Cancer Surgery,"PREDINA, JARROD",UNIVERSITY OF PENNSYLVANIA,PA,"$67,578"
Lung Cancer,2017,NCI,5F32CA210421-02,,Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,"DANAI, LAURA",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$56,694"
Lung Cancer,2017,NCI,1U01CA209414-01A1,,The Boston Lung Cancer Survival Cohort,"CHRISTIANI, DAVID",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$1,694,687"
Lung Cancer,2017,NIMHD,1S06GM123544-01,7195,Advocacy Intervention for Smoke-Free Policy in Lakota Communities,"HENDERSON, JEFFREY",BLACK HILLS CTR/AMERICAN INDIAN HEALTH,SD,"$113,451"
Lung Cancer,2017,NIEHS,1S06GM123544-01,7195,Advocacy Intervention for Smoke-Free Policy in Lakota Communities,"HENDERSON, JEFFREY",BLACK HILLS CTR/AMERICAN INDIAN HEALTH,SD,"$61,573"
Lung Cancer,2017,NIGMS,1S06GM123544-01,7195,Advocacy Intervention for Smoke-Free Policy in Lakota Communities,"HENDERSON, JEFFREY",BLACK HILLS CTR/AMERICAN INDIAN HEALTH,SD,"$24,977"
Lung Cancer,2017,NCI,5U01CA199215-03,,Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts,"RUDIN, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$570,759"
Lung Cancer,2017,NCI,5K22CA190521-03,,The role of autophagy in Kras-driven lung cancer,"GUO, YANXIANG",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$209,628"
Lung Cancer,2017,NHLBI,5K08HL129081-02,,Genetic and Molecular Dissection of Pulmonary Neuroendocrine (NE) Cell Development,"KUO, CHRISTIN",STANFORD UNIVERSITY,CA,"$168,048"
Lung Cancer,2017,NCI,5R01CA193220-03,,Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma,"BEVERLY, LEVI",UNIVERSITY OF LOUISVILLE,KY,"$352,275"
Lung Cancer,2017,NHGRI,5U01HG007253-04,,"Integrated, Individualized, Intelligent Prescribing (I3P)","DENNY, JOSHUA",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$936,331"
Lung Cancer,2017,NCI,5P01CA087971-14,5030,Biostatistics and Data Coordinating Core (BDCC),"PUTT, MARY",UNIVERSITY OF PENNSYLVANIA,PA,"$119,390"
Lung Cancer,2017,NCI,5P01CA087971-14,5031,Administrative Core,"GLATSTEIN, ELI",UNIVERSITY OF PENNSYLVANIA,PA,"$65,910"
Lung Cancer,2017,NCI,5P01CA087971-14,5032,Project 1: A Randomized Clinical Trial for Patients with,"FRIEDBERG, JOSEPH",UNIVERSITY OF PENNSYLVANIA,PA,"$240,236"
Lung Cancer,2017,NCI,5P01CA087971-14,5033,Project 2: Evaluation and Augmentation of Anti-tumoral Immune Responses Induced b,"ALBELDA, STEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$179,541"
Lung Cancer,2017,NCI,5P01CA087971-14,5034,Project 3: Evaluating and Modulating the Negative Impact of Surgically-Induced Cytokines on Tumor Response to Photodynamic Therapy,"CENGEL, KEITH",UNIVERSITY OF PENNSYLVANIA,PA,"$178,047"
Lung Cancer,2017,NCI,5P01CA087971-14,5035,Project 4: Understanding and Optimizing Vascular Response to,"BUSCH, THERESA",UNIVERSITY OF PENNSYLVANIA,PA,"$214,923"
Lung Cancer,2017,NCI,5R01CA183793-04,,Statistical methods for genomic analysis of heterogeneous tumors,"WANG, WENYI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$330,766"
Lung Cancer,2017,NCI,5U54CA199081-03,6442,Imaging and Radiochemistry Core,"ZANZONICO, PAT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$144,506"
Lung Cancer,2017,NCI,5U01CA186145-04,,Non-invasive evaluation of indeterminate pulmonary nodules,"MASSION, PIERRE",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$387,713"
Lung Cancer,2017,NCI,5R01CA181746-03,,Harnessing beneficial off-target effects of kinase inhibitors in lung cancer,"RIX, UWE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$464,563"
Lung Cancer,2017,NCI,5P30CA047904-29,6387,Biobehavioral Oncology Program (Project-004),"BOVBJERG, DANA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$34,500"
Lung Cancer,2017,NCI,5P30CA047904-29,6388,Cancer Epidemiology and Prevention Program (Project-005),"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$35,797"
Lung Cancer,2017,NCI,5P30CA047904-29,6392,Lung Cancer Program (Project-009),"SOCINSKI, MARK",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$34,500"
Lung Cancer,2017,NCI,5R01CA172211-05,,Integrative Analysis to Identify Therapeutic Targets for Lung Cancer,"XIAO, GUANGHUA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$329,925"
Lung Cancer,2017,NCI,5U54CA199075-03,6374,Multiscale Nanotechnologies for Comprehensive Assessment of Lung Cancer in Blood,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$491,768"
Lung Cancer,2017,NCI,5U54CA199075-03,6373,Multimodality Self-Assembling and Disassembling Nanoparticles,"RAO, JIANGHONG",STANFORD UNIVERSITY,CA,"$282,111"
Lung Cancer,2017,NCI,5U54CA199075-03,6372,Clinical Translational Core,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$202,367"
Lung Cancer,2017,NIGMS,5SC1CA190505-04,,Disrupting Polyisoprenylated Protein Function for Lung Cancer Therapy,"LAMANGO, NAZARIUS",FLORIDA AGRICULTURAL AND MECHANICAL UNIV,FL,"$333,000"
Lung Cancer,2017,NCI,5P50CA196530-03,6946,Biostatistics and Bioinformatics Core,"ZELTERMAN, DANIEL",YALE UNIVERSITY,CT,"$197,883"
Lung Cancer,2017,NCI,5P50CA196530-03,6947,"Biospecimen, Pathology, and Genomics Core","RIMM, DAVID",YALE UNIVERSITY,CT,"$311,862"
Lung Cancer,2017,NCI,5P50CA196530-03,6948,Administrative Core,"HERBST, ROY",YALE UNIVERSITY,CT,"$148,979"
Lung Cancer,2017,NCI,5P50CA196530-03,6949,Immunotherapy of Advanced Non-small Cell Lung Cancer,"CHEN, LIEPING",YALE UNIVERSITY,CT,"$299,595"
Lung Cancer,2017,NCI,5P50CA196530-03,6950,MicroRNA Therapeutics in Non-small Cell Lung Cancer,"SLACK, FRANK",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$384,723"
Lung Cancer,2017,NCI,5P50CA196530-03,6951,Targeting the EGFR Pathway in Lung Adenocarcinoma,"POLITI, KATERINA",YALE UNIVERSITY,CT,"$352,755"
Lung Cancer,2017,NCI,5P50CA196530-03,6952,Personalized Prevention: Smoking Cessation in Lung Nodule Patients,"TOLL, BENJAMIN",YALE UNIVERSITY,CT,"$316,971"
Lung Cancer,2017,NCI,5P50CA196530-03,6953,Yale SPORE in Lung Cancer Developmental Research Program,"HERBST, ROY",YALE UNIVERSITY,CT,"$143,616"
Lung Cancer,2017,NCI,5P50CA196530-03,6954,Yale SPORE in Lung Cancer Career Development Program,"CHEN, LIEPING",YALE UNIVERSITY,CT,"$143,616"
Lung Cancer,2017,NCI,5K07CA178120-05,,PREDICTIVE MODELING IN LUNG CANCER,"PURI, VARUN",WASHINGTON UNIVERSITY,MO,"$158,167"
Lung Cancer,2017,NCI,5R01CA196759-03,,Testing the Impact of Tobacco Product Graphic Warning Labels at Retail Point-of-Sale,"SHADEL, WILLIAM",RAND CORPORATION,CA,"$439,091"
Lung Cancer,2017,NCI,5K22CA187931-03,,Identification of Novel Mechanisms of Autophagy Regulation for Cancer,"STROHECKER, ANNE",OHIO STATE UNIVERSITY,OH,"$193,428"
Lung Cancer,2017,NCI,5K22CA201088-02,,Elucidating the role of the Nrf2 anti-oxidant pathway in lung adenocarcinoma,"PAPAGIANNAKOPOULOS, THALES",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$190,080"
Lung Cancer,2017,NCI,1F30CA216891-01,,Investigating the role of EphA2 receptor tyrosine kinase in anti-tumor immunity mediated through programmed cell death ligand 2 (PD-L2) in non-small cell lung cancer (NSCLC),"SHIUAN, EILEEN",VANDERBILT UNIVERSITY,TN,"$28,712"
Lung Cancer,2017,NIA,5R03AG053314-02,,Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR),"NIPP, RYAN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$128,250"
Lung Cancer,2017,NCI,5P30CA134274-10,8047,Population Science (PS),"DORGAN, JOANNE",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$52,961"
Lung Cancer,2017,NCI,5R01CA177786-05,,Novel mechanisms of oncogenic transformation in lung cancer,"EISCHEN, CHRISTINE",THOMAS JEFFERSON UNIVERSITY,PA,"$323,700"
Lung Cancer,2017,NCI,5R21CA202793-02,,Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma,"OSTROFF, JAMIE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$223,677"
Lung Cancer,2017,NCI,1F31CA216915-01,,Understanding the consequences of oncogenic mutations on FGFR signaling,"RYAN, MOLLY",YALE UNIVERSITY,CT,"$44,044"
Lung Cancer,2017,NCI,5R01CA187143-04,,A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients,"BADR, HODA",BAYLOR COLLEGE OF MEDICINE,TX,"$456,456"
Lung Cancer,2017,NIAAA,5R01AA024770-02,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$494,761"
Lung Cancer,2017,NIEHS,5R01ES026151-03,,The epigenetic mechanism of hexavalent chromium carcinogenesis,"YANG, CHENGFENG",UNIVERSITY OF KENTUCKY,KY,"$329,156"
Lung Cancer,2017,NCI,1F32CA210516-01A1,,Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma,"HASTINGS, KATHERINE",YALE UNIVERSITY,CT,"$56,694"
Lung Cancer,2017,NCI,5P01CA087969-18,8097,Project 4: Statistical Innovations,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$167,985"
Lung Cancer,2017,NCI,5U01CA199252-03,,A multi-faceted approach to identifying K-Ras synthetic lethal relationships,"HAIGIS, KEVIN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$1,041,188"
Lung Cancer,2017,NCI,1F30CA213817-01A1,,Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram,"FALLS, KELLY",UNIVERSITY OF IOWA,IA,"$34,112"
Lung Cancer,2017,NCI,1F31CA217032-01,,Role of ER stress-driven IRE1-XBP1 Signaling in Lung Cancer Pathogenesis,"CROWLEY, MICHAEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$44,044"
Lung Cancer,2017,NCI,5K07CA181480-04,,Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes,"LIU, YANHONG",BAYLOR COLLEGE OF MEDICINE,TX,"$127,883"
Lung Cancer,2017,NCI,5R01CA199376-03,,Targeting tumor endothelium for cancer surveillance and immunotherapy,"SHARMA, SONIA",LA JOLLA INST FOR ALLERGY & IMMUNOLGY,CA,"$404,888"
Lung Cancer,2017,NCI,5R33CA191245-03,,Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis,"WU, YUN",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$391,724"
Lung Cancer,2017,NCI,5R01CA207442-02,,Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer Screening,"OSTROFF, JAMIE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,413"
Lung Cancer,2017,NIGMS,5R01GM113046-05,,Chemoenzymatic methods for the detection of cellsurface glycans,"WU, PENG",SCRIPPS RESEARCH INSTITUTE,CA,"$465,890"
Lung Cancer,2017,NCI,5R01CA207048-02,,Smoking cessation in lung cancer screening: integrated digital/clinical approach,"HAYS, J",MAYO CLINIC ROCHESTER,MN,"$601,796"
Lung Cancer,2017,NIBIB,5R01EB022433-02,,Lymph node-targeted molecular vaccines,"IRVINE, DARRELL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$347,714"
Lung Cancer,2017,NCI,1R01CA212014-01A1,,Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry,"HENDERSON, LOUISE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$628,514"
Lung Cancer,2017,NCI,5R01CA149705-07,,Cell Phone RDD Sampling to Reach Young Adults for Tobacco Control Surveillance,"DELNEVO, CRISTINE",RBHS-SCHOOL OF PUBLIC HEALTH,NJ,"$508,216"
Lung Cancer,2017,NCI,5R01CA208303-02,,Developing a targeted chemoprevention strategy for Non-Small Cell Lung Cancer,"GOMPERTS, BRIGITTE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,275"
Lung Cancer,2017,NCI,5U01CA143062-07,,Radiomics of NSCLC,"GILLIES, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$583,540"
Lung Cancer,2017,NCI,5R01CA175370-05,,Notch ligands in regulation of anti-cancer immunity,"CARBONE, DAVID",OHIO STATE UNIVERSITY,OH,"$314,259"
Lung Cancer,2017,NCI,5UM1CA182876-04,,Cancer epidemiology cohorts in Shanghai and Singapore,"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$861,150"
Lung Cancer,2017,NCI,5R01CA192438-04,,Epidemiology of the four most frequent cancers following breast cancer,"MALONE, KATHLEEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$956,771"
Lung Cancer,2017,NCI,5R01CA196873-03,,Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs,"JOSEPH, ANNE",UNIVERSITY OF MINNESOTA,MN,"$617,815"
Lung Cancer,2017,NCI,5R01CA195654-04,,SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking,"SMITH, MEGAN",YALE UNIVERSITY,CT,"$431,898"
Lung Cancer,2017,NCI,5R01CA207078-02,,Optimizing Effectiveness of Smoking Cessation Intervention During LDCT screening for Lung Cancer,"CINCIRIPINI, PAUL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$653,903"
Lung Cancer,2017,NIDA,5R01DA042685-02,,Impact of smoking and its cessation on systemic and airway immune activation,"LIN, NINA",BOSTON MEDICAL CENTER,MA,"$792,371"
Lung Cancer,2017,NCI,5R01CA185308-04,,Phospho-sulindac for Lung Cancer Treatment,"RIGAS, BASIL",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$346,111"
Lung Cancer,2017,NCI,5R00CA187035-04,,Triggering the dopamine pathway to inhibit lung cancer progression,"HOEPPNER, LUKE",UNIVERSITY OF MINNESOTA,MN,"$249,000"
Lung Cancer,2017,NCI,5P20CA202921-03,5624,Administration Core,"SPICER, PAUL",UNIVERSITY OF OKLAHOMA NORMAN,OK,"$136,429"
Lung Cancer,2017,NCI,5P20CA202921-03,5625,Vaping among Smokers:  a Cherokee Nation Cohort Study,"RHOADES, DOROTHY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$89,260"
Lung Cancer,2017,NCI,5U54CA198999-03,6198,Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer,"KABANOV, ALEXANDER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$505,472"
Lung Cancer,2017,NCI,5U01CA199284-03,,Comparative Modeling of Lung Cancer Prevention and Control Policies,"MEZA, RAFAEL",UNIVERSITY OF MICHIGAN,MI,"$1,765,010"
Lung Cancer,2017,NCI,5U54CA202995-03,6987,Outreach Core,"STUART, MOIRA",NORTHEASTERN ILLINOIS UNIVERSITY,IL,"$106,125"
Lung Cancer,2017,NCI,5U54CA203000-03,6999,Outreach Core,"GIACHELLO, AIDA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$112,558"
Lung Cancer,2017,NCI,2R01CA163591-06,,Tumor Cell Dependence on Host Metabolism,"WHITE, EILEEN","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$440,730"
Lung Cancer,2017,NCI,5R01CA190578-04,,Sox9 signaling in lung adenocarcinoma,"PINE, SHARON",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$323,793"
Lung Cancer,2017,NCI,5K22CA200912-02,,Investigating the development and maintenance of tumor-associated tertiary lymphoid structures in an autochthonous mouse model of lung adenocarcinoma,"JOSHI, NIKHIL",YALE UNIVERSITY,CT,"$195,588"
Lung Cancer,2017,NCI,5R01CA197136-03,,Radiation-Induced Tumor Cell Migration,"GRAVES, EDWARD",STANFORD UNIVERSITY,CA,"$362,525"
Lung Cancer,2017,NCI,5U01CA196386-03,,Coordinating Center:  Molecular and Cellular Findings of Screen-Detected Lesions,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,NH,"$347,354"
Lung Cancer,2017,NCI,5R01CA164533-05,,Community Intervention to Reduce Tobacco Use among Pregnant Alaska Native Women,"PATTEN, CHRISTI",MAYO CLINIC ROCHESTER,MN,"$459,116"
Lung Cancer,2017,NCI,5R21CA209121-02,,Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,"KERN, JEFFREY",NATIONAL JEWISH HEALTH,CO,"$177,432"
Lung Cancer,2017,NCI,5R01CA131261-08,,"Studying the initiation, progression and therapy of lung cancer in mouse models","MCMAHON, MARTIN",UNIVERSITY OF UTAH,UT,"$329,788"
Lung Cancer,2017,NCI,5P01CA180945-04,8668,Evaluating EHR-Based Health System Modifications for the Chronic Care of Smoking,"FIORE, MICHAEL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$231,293"
Lung Cancer,2017,NCI,5P01CA180945-04,8670,Testing Intervention Components for the Smoker who is Unwilling to Quit,"MERMELSTEIN, ROBIN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$146,611"
Lung Cancer,2017,NCI,5P01CA180945-04,8671,A Comparative Effectiveness RCT of Optimized Cessation Treatments,"PIPER, MEGAN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$72,562"
Lung Cancer,2017,NCI,5P01CA180945-04,8672,Testing Relapse Recovery Intervention Components,"BAKER, TIMOTHY",UNIVERSITY OF WISCONSIN-MADISON,WI,"$89,014"
Lung Cancer,2017,NCI,5P20CA192993-04,5279,The TREND Partnership Administrative Core,"SHEFFER, CHRISTINE",CITY COLLEGE OF NEW YORK,NY,"$73,854"
Lung Cancer,2017,NCI,5P20CA192993-04,5281,Research Education Curriculum and Training (REACT) Program,"SHEFFER, CHRISTINE",CITY COLLEGE OF NEW YORK,NY,"$93,384"
Lung Cancer,2017,NCI,5R01CA193828-03,,Modulation of Bcl2 BH4 and mTOR in lung cancer therapeutics,"DENG, XINGMING",EMORY UNIVERSITY,GA,"$356,850"
Lung Cancer,2017,NCI,5R01CA202956-02,,Optimizing Treatment of Lung Cancer Patients with Comorbidities,"WISNIVESKY, JUAN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$730,394"
Lung Cancer,2017,NCI,5R01CA202761-02,,Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung SABR,"SAWANT, AMIT",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$586,093"
Lung Cancer,2017,NCI,2R44CA189549-02A1,,Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen,"GARLAND, WILLIAM","TOSK, INC.",CA,"$1,043,722"
Lung Cancer,2017,NCI,5R01CA178744-03,,"Bayesian methods for complex, high-dimensional functional data in cancer research","MORRIS, JEFFREY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$358,240"
Lung Cancer,2017,NCI,5P20CA192991-04,5252,TREND PARTNERSHIP ADMINISTRATIVE CORE,"OSTROFF, JAMIE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$113,535"
Lung Cancer,2017,NCI,5P20CA192991-04,5254,RESEARCH EDUCATION CURRICULUM AND TRAINING (REACT) PROGRAM,"OSTROFF, JAMIE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$92,177"
Lung Cancer,2017,NIDA,5K23DA040933-02,,"Health Literacy and Smoking Cessation in Low-SES, Diverse Smokers","HOOVER, DIANA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$168,043"
Lung Cancer,2017,NHLBI,5K23HL133476-02,,CT Characteristics of Emphysema for Evaluation of Pulmonary Nodules,"KINSEY, CHARLES",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$179,248"
Lung Cancer,2017,NCI,5P20CA202923-03,5646,Administrative Core,"KHAN, SOHAIL",CHEROKEE NATION,OK,"$30,953"
Lung Cancer,2017,NCI,5P20CA202923-03,5647,"Vaping among Smokers, a Cherokee Nation Cohort Study","COMIFORD, ASHLEY",CHEROKEE NATION,OK,"$21,320"
Lung Cancer,2017,NCI,5R01CA199143-02,,Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT,"BRANDON, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$570,307"
Lung Cancer,2017,NCI,5R01CA143167-07,,DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome,"HILL, DANA",CHILDREN'S RESEARCH INSTITUTE,DC,"$407,577"
Lung Cancer,2017,NCI,5R25CA186882-04,,Distance Education to Engage Alaskan Community Health Aides in Cancer Control,"CUEVA, MELANY",ALASKA NATIVE TRIBAL HEALTH CONSORTIUM,AK,"$160,384"
Lung Cancer,2017,NCI,5U01CA196405-04,,"Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma","MASSION, PIERRE",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$727,581"
Lung Cancer,2017,NCI,5R01CA207228-02,,Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized Trial,"TAYLOR, KATHRYN",GEORGETOWN UNIVERSITY,DC,"$606,515"
Lung Cancer,2017,NCI,5R01CA207158-02,,Implementation of Smoking Cessation Services within NCI NCORP Community Sites with Organized Lung Cancer Screening Programs,"FOLEY, KRISTIE",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$544,303"
Lung Cancer,2017,NCI,5U54CA209975-02,8663,The tumor ecosystem in cancer progression and immunotherapeutic response,"RUDENSKY, ALEXANDER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$544,850"
Lung Cancer,2017,NCI,5R01CA208756-02,,(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity,"HACOHEN, NIR","BROAD INSTITUTE, INC.",MA,"$518,165"
Lung Cancer,2017,NCI,5U01CA196408-03,,"Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer","DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$764,788"
Lung Cancer,2017,NCI,5R01CA186193-04,,Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies,"QUARANTA, VITO",VANDERBILT UNIVERSITY,TN,"$562,502"
Lung Cancer,2017,NIDA,5K01DA042687-02,,"Clinical and Economic Outcomes of HIV, Cigarette Smoking, and Smoking Cessation Interventions","REDDY, KRISHNA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,670"
Lung Cancer,2017,NCI,5R01CA208620-02,,(PQ1) Epigenetic effects of the premalignant field,"TERADA, LANCE",UT SOUTHWESTERN MEDICAL CENTER,TX,"$372,671"
Lung Cancer,2017,NCI,5R01CA208642-02,,(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer,"SHACKELFORD, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,275"
Lung Cancer,2017,NCI,5R44CA206844-02,,Buccal Nanocytological Risk Stratification to Personalize Lung Cancer Screening,"SUBRAMANIAN, HARIHARAN","NANOCYTOMICS, LLC",IL,"$694,885"
Lung Cancer,2017,NCI,5P50CA070907-19,5890,Molecular Signatures for Individualizing Lung Cancer Therapy,"MINNA, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$418,554"
Lung Cancer,2017,NCI,5P50CA070907-19,5891,Epidemiologic Studies of Germline Polymorphisms in miRNA Pathways: Risk of Lung Cancer Development and Recurrence,"WU, XIFENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$447,453"
Lung Cancer,2017,NCI,5P50CA070907-19,5892,Preclinical Development and Clinical Testing of MEK and PI3K Targeted Therapy for KRAS-mutant NSCLC,"SCAGLIONI, PIER",UT SOUTHWESTERN MEDICAL CENTER,TX,"$318,714"
Lung Cancer,2017,NCI,5P50CA070907-19,5893,Therapeutic Targeting of Telomerase in Lung Cancer Stem Cells,"SHAY, JERRY",UT SOUTHWESTERN MEDICAL CENTER,TX,"$203,270"
Lung Cancer,2017,NCI,5P50CA070907-19,5894,Administrative Core,"MINNA, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$204,191"
Lung Cancer,2017,NCI,5P50CA070907-19,5895,Tissue Resources and Molecular Pathology,"WISTUBA, IGNACIO",UT SOUTHWESTERN MEDICAL CENTER,TX,"$252,790"
Lung Cancer,2017,NCI,5P50CA070907-19,5896,Biostatistics and Bioinformatics Core,"XIE, YANG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$293,529"
Lung Cancer,2017,NCI,5P50CA070907-19,5897,Developmental Research Program,"MINNA, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$80,749"
Lung Cancer,2017,NCI,5P50CA070907-19,5898,Career Development Program,"MINNA, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$80,749"
Lung Cancer,2017,NCI,5R01CA183854-04,,Bayesian approaches for missingness and causality in cancer and behavior studies,"DANIELS, MICHAEL","UNIVERSITY OF TEXAS, AUSTIN",TX,"$438,914"
Lung Cancer,2017,NCI,5P30CA068485-22,7774,DEVELOPMENTAL FUNDS (Core-002),"PIETENPOL, JENNIFER",VANDERBILT UNIVERSITY,TN,"$544,647"
Lung Cancer,2017,NCI,5P30CA068485-22,7796,Cancer Health Outcomes and Control Research Program (CO) (Project-007),"FRIEDMAN, DEBRA",VANDERBILT UNIVERSITY,TN,"$87,030"
Lung Cancer,2017,NCI,5K22CA201036-02,,Defining epigenetic vulnerabilities of subtype-specific lung cancers,"FILLMORE, CHRISTINE",UNIVERSITY OF KENTUCKY,KY,"$163,736"
Lung Cancer,2017,NCI,1R43CA217394-01,,Novel targeted therapeutic for advanced metastatic disease,"YU, BO","LARIX BIOSCIENCE, LLC",CA,"$224,981"
Lung Cancer,2017,NCI,1R41CA210877-01A1,,Development of a new small molecule therapeutic for the treatment of resistant breast cancer,"LOUIE, STAN","VIOMEDIX, LLC",CA,"$279,906"
Lung Cancer,2017,NCI,1R41CA213479-01A1,,Investigation of antibody-drug conjugates of a novel target,"CUI, JIE","WNTRIX, INC.",TX,"$225,000"
Lung Cancer,2017,NCI,1R43CA217428-01,,Mobile app for positive psychology intervention to enhance smoking cessation outcomes,"BROWN, JASON","HEALTH BEHAVIOR SOLUTIONS, INC.",TX,"$224,859"
Lung Cancer,2017,NCI,1R43CA206840-01A1,,Giant Macrophage-like Cells as a blood-based Biomarker for Lung Cancer Recurrence,"ADAMS, DANIEL","CREATV MICROTECH, INC.",MD,"$182,850"
Lung Cancer,2017,NCI,2R44CA199142-02A1,,Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens,"ORBAI, LUCIAN","CELL DATA SCIENCES, INC.",CA,"$735,637"
Lung Cancer,2017,NCI,1R44CA217587-01,,"Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer","PEREZ, KRISTY","CIVATECH ONCOLOGY, INC.",NC,"$296,866"
Lung Cancer,2017,NCI,1R01CA210806-01A1,,Optimizing Lung Cancer Treatment in HIV Infected Persons,"SIGEL, KEITH",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$609,180"
Lung Cancer,2017,NCI,5R01CA207229-02,,Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs,"TOLL, BENJAMIN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$592,850"
Lung Cancer,2017,NCI,5R01CA092596-12,,Human CYP2A and respiratory tract xenobiotic toxicity,"DING, XINXIN",SUNY POLYTECHNIC INSTITUTE,NY,"$358,935"
Lung Cancer,2017,NCI,5R01CA208709-02,,PQ 5 Exploring whole mitochondrial genome of screen detected pre-neoplastic lung lesions by novel approaches,"SIDRANSKY, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$379,327"
Lung Cancer,2017,NCI,5K08CA197389-02,,Evolution of resistance of EGFR mutant non-small cell lung cancer,"HATA, AARON",MASSACHUSETTS GENERAL HOSPITAL,MA,"$179,280"
Lung Cancer,2017,NCI,5U24CA210986-02,,Center of Excellence for High Throughput Proteogenomic Characterization,"CARR, STEVEN","BROAD INSTITUTE, INC.",MA,"$1,288,045"
Lung Cancer,2017,NCI,5R01CA206540-02,,Molecular and cellular mechanisms of SCLC metastasis,"SAGE, JULIEN",STANFORD UNIVERSITY,CA,"$441,854"
Lung Cancer,2017,NCI,5K99CA201618-02,,Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer,"CHRISTENSEN, CAMILLA",DANA-FARBER CANCER INST,MA,"$128,690"
Lung Cancer,2017,NCI,5U01CA214165-02,,Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer,"HERMAN, JAMES",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$581,405"
Lung Cancer,2017,NCI,5F32CA206400-02,,Defining the role of Wnt5a in LKB1-deficient non-small cell lung cancer metastasis,"BRUN, SONJA",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$57,066"
Lung Cancer,2017,NCI,5F99CA212456-02,,New therapeutic opportunities from mining polypharmacology mechanisms of ceritinib in ALK-negative non-small cell lung cancer,"KUENZI, BRENT",UNIVERSITY OF SOUTH FLORIDA,FL,"$34,324"
Lung Cancer,2017,NCI,5U01CA214182-02,,The Boston University-UCLA Lung Cancer Biomarker Development Lab,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$860,456"
Lung Cancer,2017,NCI,5U01CA214195-02,,The EDRN Mesothelioma Biomarker Discovery Laboratory,"PASS, HARVEY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$812,360"
Lung Cancer,2017,NCI,5R01CA205608-02,,(PQ1) Progression of the airway field of injury to Kras mutant lung cancer,"SCHEET, PAUL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$346,909"
Lung Cancer,2017,NCI,5R44CA203050-03,,Personalized Smoking Cessation Tool Based on Patient Lung CT Image,"KEITH, LAUREN","IMBIO, LLC",MN,"$622,479"
Lung Cancer,2017,NCI,5U01CA214201-02,,Novel approaches to study immune responses to post translational modifications for cancer detection,"LABAER, JOSHUA",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$462,286"
Lung Cancer,2017,NCI,5P01CA138338-07,8816,Core A - Administrative Core,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA,MN,"$2,288"
Lung Cancer,2017,NCI,5P01CA138338-07,8817,Core B - The Clinical and Biomarkers Core,"HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA,MN,"$666,961"
Lung Cancer,2017,NCI,5P01CA138338-07,8818,Core C - Biostatistics Core,"STRAM, DANIEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$191,785"
Lung Cancer,2017,NCI,5P01CA138338-07,8819,Project 1 - Ethnic Differences in Smoking-Related Biomarkers and Risk of Lung Cancer,"PARK, SUNGSHIM",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$833,662"
Lung Cancer,2017,NCI,5P01CA138338-07,8820,"Project 2 - 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) -Hydroxy Glucuronides, Metabolic Profiling and Activation","MURPHY, SHARON",UNIVERSITY OF MINNESOTA,MN,"$219,486"
Lung Cancer,2017,NCI,5P01CA138338-07,8821,"Project 3 - Ethnic/racial Differences in Metabolism and DNA Adduct Formation by 1,3-Butadiene","TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA,MN,"$339,603"
Lung Cancer,2017,NCI,5P01CA138338-07,8822,Project 4 - Oral Cell DNA Adducts and Urinary Biomarkers to Investigate Ethnic/Racial Differences in Lung Cancer Susceptibility,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA,MN,"$191,002"
Lung Cancer,2017,NCI,2P30CA168524-06,8710,Clinical Pharmacology Shared Resource,"REED, GREGORY",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$116,532"
Lung Cancer,2017,FIC,5R21TW010637-02,,"Network for Tobacco Control among Women in Antioquia, Colombia","SCARINCI, ISABEL",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$146,971"
Lung Cancer,2017,NCI,5R21CA198558-02,,Development of circulating biomarker for lung cancer,"HUANG, QIHONG",WISTAR INSTITUTE,PA,"$193,212"
Lung Cancer,2017,NCI,5U54CA163069-07,6962,Developing Personalized Smoking Treatment in the Southern Community Cohort Study,"SANDERSON, MAUREEN",MEHARRY MEDICAL COLLEGE,TN,"$74,706"
Lung Cancer,2017,NCI,5U54CA163072-08,6540,Developing Personalized Smoking Treatment in the Southern Community Cohort Study,"TINDLE, HILARY",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$171,918"
Lung Cancer,2017,NCI,2P01CA042063-31,5194,Project 1:  Evolution of transcriptional programs in lung cancer progression,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$420,760"
Lung Cancer,2017,NCI,2P01CA042063-31,5196,Project 3:  Targeting epigenetic regulators in cancer,"LEES, JACQUELINE",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$352,717"
Lung Cancer,2017,NCI,1R25CA217693-01,,Tobacco Treatment Training for Cancer Care Providers,"OSTROFF, JAMIE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$252,017"
Lung Cancer,2017,NCI,5R01CA201124-02,,Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$259,646"
Lung Cancer,2017,NCI,5R01CA210360-02,,Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$627,525"
Lung Cancer,2017,NCI,5U54CA163066-07,6610,Developing Personalized Smoking Treatment in the Southern Community Cohort Study,"SELOVE, REBECCA",TENNESSEE STATE UNIVERSITY,TN,"$52,871"
Lung Cancer,2017,NIBIB,1P41EB024495-01,5626,Imaging Agents for Inflammatory Components of Malignancy,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$259,734"
Lung Cancer,2017,NIDA,5R01DA043950-24,,Effect of Tobacco Advocacy at the State Level,"GLANTZ, STANTON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$511,397"
Lung Cancer,2017,NCI,1P01CA217806-01,5790,Program Integration and Management,"HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA,MN,"$399,541"
Lung Cancer,2017,NCI,1P01CA217806-01,5791,"Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products","HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA,MN,"$399,540"
Lung Cancer,2017,NCI,1P01CA217806-01,5795,Core A: Administrative Core,"HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA,MN,"$399,539"
Lung Cancer,2017,NCI,1P01CA217806-01,5796,Core B: Biomarker and Constituent Core,"STEPANOV, IRINA",UNIVERSITY OF MINNESOTA,MN,"$399,539"
Lung Cancer,2017,NCI,3R01CA188446-04S1,,A high efficiency imager for real-time lung cancer monitoring during radiotherapy,"BERBECO, ROSS",DANA-FARBER CANCER INST,MA,"$256,320"
Lung Cancer,2017,NCI,5P30CA124435-10,7151,Population Sciences Research Program (Project-008),"HAILE, ROBERT",STANFORD UNIVERSITY,CA,"$52,810"
Lung Cancer,2017,NCI,5P30CA014089-42,8292,Cancer Control Research Program (Project-005),"PENTZ, MARY ANN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$61,950"
Lung Cancer,2017,NCI,5P30CA016520-41,4008,Tobacco and Environmental Carcinogenesis Research Program,"SCHNOLL, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$73,101"
Lung Cancer,2017,NCI,5P30CA062203-20,4041,"Cancer Prevention, Outcomes and Survivorship Program (CPOS)","WENZEL, LARI",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$16,397"
Lung Cancer,2017,NCI,5P30CA016058-41,5097,Cancer Control Research Program (CC),"PASKETT, ELECTRA",OHIO STATE UNIVERSITY,OH,"$45,733"
Lung Cancer,2017,NCI,5P01CA203657-02,8382,Project 4: The role of codon bias in RAS tumorigenesis,"COUNTER, CHRISTOPHER",DUKE UNIVERSITY,NC,"$664,123"
Lung Cancer,2017,NIEHS,1R01ES028321-01,,ROS and Nrf2 in arsenic carcinogenesis,"ZHANG, ZHUO",UNIVERSITY OF KENTUCKY,KY,"$344,250"
Lung Cancer,2017,NCI,1R01CA217861-01,,Optimizing risk messages to promote waterpipe tobacco cessation in young adults,"MAYS, DARREN",GEORGETOWN UNIVERSITY,DC,"$372,066"
Lung Cancer,2017,NCI,1R01CA219083-01,,The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells,"MOON, EDMUND",UNIVERSITY OF PENNSYLVANIA,PA,"$368,288"
Lung Cancer,2017,NCI,5P30CA082709-18,7033,Cancer Prevention and Control,"LOEHRER, PATRICK",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$145,601"
Lung Cancer,2017,NLM,1R01LM012601-01,,Biomedical Computing and Informatics Strategies for Precision Medicine,"MOORE, JASON",UNIVERSITY OF PENNSYLVANIA,PA,"$359,154"
Lung Cancer,2017,NIEHS,1R01ES028263-01,,Reduced reactive oxygen species and oxidative phosphorylation in arsenic-induced cancer stem cells,"CHEN, FEI",WAYNE STATE UNIVERSITY,MI,"$337,277"
Lung Cancer,2017,NIA,1R03AG056439-01,,Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer,"WONG, MELISA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$118,875"
Lung Cancer,2017,NCI,1R01CA219347-01,,Targeting bidirectional signaling in lung stroma and cancer cells,"RIX, UWE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$505,460"
Lung Cancer,2017,NCI,5P30CA118100-13,8410,Cancer Control Program,"WILLMAN, CHERYL",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$71,081"
Lung Cancer,2017,NCI,5P30CA118100-13,8411,"Cancer Genetics, Epigenetics, and Genomics Program","WILLMAN, CHERYL",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$79,554"
Lung Cancer,2017,NCI,1R01CA219156-01,,GSTP1-induced S-glutathionylation in lung cancer,"VAN DER VELDEN, ADRIANUS",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$356,564"
Lung Cancer,2017,NIBIB,1R01EB024864-01,,Bronchoscopic Steerable Needles for Transparenchymal Access to Lung Nodules,"ALTEROVITZ, RON",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$527,452"
Lung Cancer,2017,NCI,1R01CA218156-01,,Optimizing remotely delivered Smoking Cessation Services for Low-Income Smokers,"MCCARTHY, DANIELLE",UNIVERSITY OF WISCONSIN-MADISON,WI,"$608,321"
Lung Cancer,2017,NCI,5P30CA015704-42,5441,Research Program: Global Oncology,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$119,013"
Lung Cancer,2017,NCI,5P50CA058187-22,5507,Targeting FGFR1 Signaling in Lung Cancer,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$295,042"
Lung Cancer,2017,NCI,5P50CA058187-22,5508,Improving Outcome from EGFR Specific TKIs Using Rational Combinations,"DEGREGORI, JAMES",UNIVERSITY OF COLORADO DENVER,CO,"$295,042"
Lung Cancer,2017,NCI,5P50CA058187-22,5509,Prostacyclin and Peroxisome Proliferator-Activated Receptor-Gamma in Lung Cancer,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$295,040"
Lung Cancer,2017,NCI,5P50CA058187-22,5510,Predictors of Lung Nodule Malignancy,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$284,665"
Lung Cancer,2017,NCI,5P50CA058187-22,5521,Tissue Bank and Biomarkers Core,"MERRICK, DANIEL",UNIVERSITY OF COLORADO DENVER,CO,"$280,464"
Lung Cancer,2017,NCI,5P50CA058187-22,5522,Clinical Trials Core,"KEITH, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$283,712"
Lung Cancer,2017,NCI,5P50CA058187-22,5523,"Biostatistics, Informatics and Bioinformatics Core","BARON, ANNA",UNIVERSITY OF COLORADO DENVER,CO,"$269,844"
Lung Cancer,2017,NCI,5P50CA058187-22,5524,Administrative Shared Resource Core,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$168,711"
Lung Cancer,2017,NCI,5P50CA058187-22,5525,Developmental Research Program,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$63,740"
Lung Cancer,2017,NCI,5P50CA058187-22,5526,Career Development Program,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$63,740"
Lung Cancer,2017,NCI,1R01CA211554-01A1,,First in human study with 18F-avb6-targeting peptide,"SUTCLIFFE, JULIE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$354,083"
Lung Cancer,2017,FIC,1R01TW010651-01,,Analytical capacity building for the study of tobacco carcinogen exposures in India,"KHARIWALA, SAMIR",UNIVERSITY OF MINNESOTA,MN,"$286,034"
Lung Cancer,2017,FIC,9R01TW010898-06,,The Political Economy of Tobacco Farming in Low-and Middle-Income Countries,"DROPE, JEFFREY","AMERICAN CANCER SOCIETY, INC.",GA,$1
Lung Cancer,2017,NCI,9R01TW010898-06,,The Political Economy of Tobacco Farming in Low-and Middle-Income Countries,"DROPE, JEFFREY","AMERICAN CANCER SOCIETY, INC.",GA,"$172,820"
Lung Cancer,2017,OD,9R01TW010898-06,,The Political Economy of Tobacco Farming in Low-and Middle-Income Countries,"DROPE, JEFFREY","AMERICAN CANCER SOCIETY, INC.",GA,"$125,000"
Lung Cancer,2017,FIC,2R01TW005964-06,,Building GIS Capacity into Tobacco Control Research Programs of East Asia,"SINGH, PRAMIL",LOMA LINDA UNIVERSITY,CA,"$311,798"
Lung Cancer,2017,NCI,1R21CA218778-01,,Discovery of Predictive Biomarkers for Cancer Therapies using Synthetic Lethality,"SINHA, SUBARNA",SRI INTERNATIONAL,CA,"$277,285"
Lung Cancer,2017,NCI,1R21CA218787-01,,Applying Chemical Biology to Target Deubiquitinating Enzymes in Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$224,460"
Lung Cancer,2017,NCI,7R21CA201486-02,,Anti-CTGF Therapy for Squamous Cell Lung Cancer,"ONAITIS, MARK",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$151,706"
Lung Cancer,2017,NCI,1R15CA219919-01,,Cancer-targeted local pulmonary immunotherapy with PD-L1 inhibitory peptide secretory genes for the treatment of lung cancer,"TAMURA, MASAAKI",KANSAS STATE UNIVERSITY,KS,"$380,000"
Lung Cancer,2017,NCI,1R21CA219608-01,,Prior-image-based CT reconstruction for low-dose lung cancer screening,"STAYMAN, JOSEPH",JOHNS HOPKINS UNIVERSITY,MD,"$213,368"
Lung Cancer,2017,NCI,3P30CA012197-42S1,,Cancer Center Support Grant,"PASCHE, BORIS",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$124,956"
Lung Cancer,2017,NCI,3P30CA016058-41S1,,Cancer Center Support Grant,"CALIGIURI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$139,874"
Lung Cancer,2017,NCI,3P30CA016058-41S2,,Cancer Center Support Grant,"CALIGIURI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$125,000"
Lung Cancer,2017,NCI,3P30CA016058-41S3,,Cancer Center Support Grant,"CALIGIURI, MICHAEL",OHIO STATE UNIVERSITY,OH,"$200,000"
Lung Cancer,2017,NCI,3P30CA016520-41S1,,Abramson Cancer Center Support Grant,"DANG, CHI",UNIVERSITY OF PENNSYLVANIA,PA,"$125,000"
Lung Cancer,2017,NCI,3P50CA058187-22S1,,SPORE in Lung Cancer,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$61,337"
Lung Cancer,2017,NCI,3P30CA076292-19S1,,Moffitt Cancer Center Support Grant,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$125,000"
Lung Cancer,2017,NCI,3P30CA076292-19S2,,Moffitt Cancer Center Support Grant,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$250,000"
Lung Cancer,2017,NCI,3P30CA134274-10S1,,UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT,"CULLEN, KEVIN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$124,964"
Lung Cancer,2017,NCI,3P30CA134274-10S2,,UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT,"CULLEN, KEVIN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$629,550"
Lung Cancer,2017,NCI,3P30CA138292-09S1,,Winship Cancer Institute Cancer Center Support Grant,"CURRAN, WALTER",EMORY UNIVERSITY,GA,"$59,999"
Lung Cancer,2017,NCI,3UM1CA173642-05S1,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$56,922"
Lung Cancer,2017,NCI,3UM1CA173642-05S2,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$165,708"
Lung Cancer,2017,NCI,3U10CA180868-04S1,,NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER,"WOLMARK, NORMAN","NRG ONCOLOGY FOUNDATION, INC.",PA,"$133,213"
Lung Cancer,2017,NCI,3P50CA180890-05S1,,Improved Models to Inform Tobacco Product Regulation,"GLANTZ, STANTON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$47,957"
Lung Cancer,2017,NCI,3R01CA184779-04S1,,An Olfactory Method for Controlling Cigarette Craving,"SAYETTE, MICHAEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$54,468"
Lung Cancer,2017,NCI,3R01CA194461-03S1,,(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression,"PARK, KWON-SIK",UNIVERSITY OF VIRGINIA,VA,"$57,872"
Lung Cancer,2017,NCI,1R03CA219737-01,,Predicting menthol cigarette and flavored cigar smokers responses to menthol or flavored tobacco restrictions: results from experimental auctions,"ROSE, SHYANIKA",TRUTH INITIATIVE FOUNDATION,DC,"$68,981"
Lung Cancer,2017,NCI,3P50CA196530-03S1,7428,Research Project,"SLACK, FRANK",YALE UNIVERSITY,CT,"$207,600"
Lung Cancer,2017,NCI,1R01CA219893-01,,"(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution","GHOSH, MOUMITA",NATIONAL JEWISH HEALTH,CO,"$442,614"
Lung Cancer,2017,NCI,3R41CA195926-01S1,,A new generation of targeted therapeutics for the treatment of cancer.,"PAWELCZAK, KATHERINE","NERX BIOSCIENCES, INC.",IN,"$49,844"
Lung Cancer,2017,NCI,1R01CA213123-01A1,,Randomized Clinical Trial of Lung Cancer Chemoprevention with Sulforaphane in Former Smokers,"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$637,010"
Lung Cancer,2017,NCI,3R21CA195317-02S1,,Assessing deformable image registration in the lung using hyperpolarized-gas MRI,"CAI, JING",DUKE UNIVERSITY,NC,"$66,465"
Lung Cancer,2017,NCI,4R00CA197762-03,,Investigating the role of the small GTPase RIT1 in lung adenocarcinoma,"BERGER, ALICE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$249,000"
Lung Cancer,2017,NCI,1R01CA212415-01A1,,Transcriptional Regulation of Lung Cancer Identity,"SNYDER, ERIC",UNIVERSITY OF UTAH,UT,"$336,921"
Lung Cancer,2017,NCI,1R01CA211944-01A1,,Role of Insulin Receptor Substrates in Kras-driven lung cancer,"KALAANY, NADA",BOSTON CHILDREN'S HOSPITAL,MA,"$404,888"
Lung Cancer,2017,NCI,1R01CA207026-01A1,,Evaluating the Tablet-based Turkish-PAINReportIt for Assessing Pain of Lung Cancer Patients Post Thoracotomy in TURKEY,"WILKIE, DIANA",UNIVERSITY OF FLORIDA,FL,"$142,588"
Lung Cancer,2017,NCI,1R01CA211705-01A1,,Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study,"ULRICH, CORNELIA",UNIVERSITY OF UTAH,UT,"$500,886"
Lung Cancer,2017,NIEHS,1R01ES027778-01A1,,Mechanism for arsenic induced carcinogenesis,"STATES, J",UNIVERSITY OF LOUISVILLE,KY,"$420,913"
Lung Cancer,2017,NCI,2U01CA164973-06,,Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study,"LE MARCHAND, LOIC",UNIVERSITY OF HAWAII AT MANOA,HI,"$3,176,130"
Lung Cancer,2017,NCI,1U01CA213285-01A1,,Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer,"HANASH, SAMIR",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$558,611"
Lung Cancer,2017,NCI,1U01CA213273-01A1,,Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC,"HEYMACH, JOHN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$615,425"
Lung Cancer,2017,NCI,1R21CA213139-01A1,,Imaging the efficacy of TRAIL-enhanced cancer immunotherapy,"PONOMAREV, VLADIMIR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$225,504"
Lung Cancer,2017,NCI,1R21CA213407-01A1,,Scatter imaging for stereotactic ablative radiation therapy of lung cancer,"CHU, JAMES",RUSH UNIVERSITY MEDICAL CENTER,IL,"$178,829"
Lung Cancer,2017,NCI,1U01CA213338-01A1,,Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer,"MINNA, JOHN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$605,070"
Lung Cancer,2017,NCI,1U01CA215709-01A1,,Precision lung cancer therapy design through multiplexed adapter measurement,"MEYER, AARON",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$446,226"
Lung Cancer,2017,NCI,1R01CA212169-01A1,,Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade,"BEG, AMER",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$393,450"
Lung Cancer,2017,NCI,1R35CA220449-01,,Metabolic Regulators of Tumor Growth and Progression,"DEBERARDINIS, RALPH",UT SOUTHWESTERN MEDICAL CENTER,TX,"$961,705"
Lung Cancer,2017,NCI,2R01CA120528-11A1,,Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma,"BUENO, RAPHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$358,443"
Lung Cancer,2017,NCI,1U01CA220413-01,,An interactive analysis toolkit for single cell RNA-seq in cancer research,"JOHNSON, WILLIAM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$397,988"
Lung Cancer,2017,NCI,1R35CA220538-01,,Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer,"SHAW, REUBEN",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$996,270"
Lung Cancer,2017,NIGMS,2R01GM042455-27,,Dynamin-1: a nexus for reciprocal regulation of endocytosis and signaling,"SCHMID, SANDRA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$340,200"
Lung Cancer,2017,NCI,3R01CA208642-02S1,,Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer,"SHACKELFORD, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$71,096"
Lung Cancer,2017,NCI,1F30CA213726-01A1,,Drug Tolerant Persisters in EGFR-mutant Non-small Cell Lung Cancer: Epigenetic Landscape and Therapeutic Targeting,"RAOOF, SANA",HARVARD MEDICAL SCHOOL,MA,"$37,600"
Lung Cancer,2017,NCI,1F31CA220804-01,,Targeting mLST8 in mTORC2-dependent lung cancer,"KIM, LAURA",VANDERBILT UNIVERSITY,TN,"$28,726"
Lung Cancer,2017,NCI,1F30CA221268-01,,Dissecting the role of the immune system in the radiation response of Kras-mutant tumors,"WISDOM, AMY",DUKE UNIVERSITY,NC,"$35,316"
Lung Cancer,2017,NCI,1F32CA220961-01,,"Personalized, Dynamic Risk-based Lung Cancer Screening","TOUMAZIS, IAKOVOS",STANFORD UNIVERSITY,CA,"$56,694"
Lung Cancer,2017,NCI,1R01CA214531-01A1,,Frizzled 9 loss and regulation in preventing the progression of pre-malignant lung lesions,"TENNIS, MEREDITH",UNIVERSITY OF COLORADO DENVER,CO,"$343,011"
Lung Cancer,2017,NCI,1F31CA213813-01A1,,Single-Cell Misregulation of NRF2 in Basal-like Breast Cancer,"PEREIRA, ELIZABETH",UNIVERSITY OF VIRGINIA,VA,"$36,397"
Lung Cancer,2017,NCI,1F32CA221103-01,,Circulating tumor cells (CTCs) in EGFR-mutant human lung cancer,"COSTANTINO, CHRISTINA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$63,666"
Lung Cancer,2017,NCI,1F31CA213982-01A1,,Developing a Novel STAT3 Inhibitor for Non-Small Cell Lung Cancer Therapy,"NJATCHA, CHRISTIAN",UNIVERSITY OF MINNESOTA,MN,"$38,444"
Lung Cancer,2017,NCI,1U01CA216468-01A1,,Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches,"LIN, STEVEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$596,334"
Lung Cancer,2017,NCI,1R01CA221158-01,,Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancer,"BOOTHMAN, DAVID",UT SOUTHWESTERN MEDICAL CENTER,TX,"$410,854"
Lung Cancer,2017,NCI,3R01CA208642-02S2,,Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer,"SHACKELFORD, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$83,477"
Lung Cancer,2017,NIEHS,3R01ES009132-13S1,,Molecular mechanism of cytochrome P4501A1 expression.,"MOORTHY, BHAGAVATULA",BAYLOR COLLEGE OF MEDICINE,TX,"$79,250"
Lung Cancer,2017,NCI,3F32CA210421-01S1,,Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell,"DANAI, LAURA",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$2,212"
Lung Cancer,2017,NCI,1R43CA213582-01A1,,Small molecule ubiquitin ligase modulators for immunotherapy of cancer,"KUMAR, SURESH","PROGENRA, INC.",PA,"$224,995"
Lung Cancer,2017,NCI,3F32CA200265-01A1S1,,Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection,"LASTWIKA, KRISTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,600"
Lung Cancer,2017,NCI,2R44CA189522-02,,"Practical high resolution microscopy of un-cut, un-embedded lung biopsies","LEVENE, MICHAEL","APPLIKATE TECHNOLOGIES, LLC",CT,"$1,091,279"
Lung Cancer,2017,NCI,1R43CA213699-01A1,,Comprehensive Liquid Biopsy for Early Stage I/II Screening and Diagnostics of Lung Cancer,"LARSON, JONATHAN","LARIAT BIOSCIENCES, INC.",MA,"$239,240"
Lung Cancer,2017,NCI,1R41CA217399-01A1,,Caveolae-Targeted Cisplatin Immunoconjugates for Effective Lung Cancer Therapy,"LEVIN, MICHAEL","CAVATAR, LLC",CA,"$299,999"
Lung Cancer,2017,NCI,2R44CA162629-02A1,,Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies,"SERRERO, GINETTE","A AND G PHARMACEUTICAL, INC.",MD,"$1,154,726"
Lung Cancer,2017,NIDCD,1R41DC016575-01,,Develop a new cisplatin-based drug combination with reduced ototoxicity,"BAO, JIANXIN","GATEWAY BIOTECHNOLOGY, INC.",OH,"$224,700"
Lung Cancer,2017,NCI,1R44CA221487-01,,Exosomal Drug Delivery,"GUPTA, RAMESH","3P BIOTECHNOLOGIES, INC.",KY,"$719,680"
Lung Cancer,2017,NCI,2R44CA192569-02,,Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery,"KULARATNE, SUMITH","ON TARGET LABORATORIES, LLC",IL,"$1,250,146"
Lung Cancer,2017,NCI,1R44CA221543-01,,Development of Novel Targeted Chemotherapeutics for the Treatment ofMalignant Pleural Mesothelioma,"SORGI, FRANK","FLAG THERAPEUTICS, INC.",NC,"$787,067"
Lung Cancer,2017,NCI,1R43CA217502-01A1,,Oral formulation for novel inhibitor of Ras driven cancers,"CANZONERI, JOSHUA","ADT PHARMACEUTICALS, LLC",AL,"$300,000"
Lung Cancer,2017,NCI,3R43CA203033-01S1,,Biopsy Probes with Real-time Multi-modality Image Guidance for Peripheral Lung Nodules,"VERTIKOV, ANDREI",LX MEDICAL CORPORATION,MA,"$50,000"
Lung Cancer,2017,NCI,3F32CA210427-01S1,,Identifying Effective Immune Checkpoint Therapy Strategies in Triple Negative Breast Cancer,"HOLLERN, DANIEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$2,528"
Lung Cancer,2017,NCI,1P20CA221696-01,5553,Cancer Research Education Program,"CHANG, SHINE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$61,147"
Lung Cancer,2017,NCI,1P20CA221697-01,5557,Cancer Research Education Program,"SOLARI WILLIAMS, KAYCE",UNIVERSITY OF HOUSTON,TX,"$188,775"
Lung Cancer,2017,NCI,3R01CA158540-05S1,,Functional characterization of the long non-coding RNA Scirocco in development an,"MARTINEZ, ERNEST",UNIVERSITY OF CALIFORNIA RIVERSIDE,CA,"$31,000"
Lung Cancer,2017,NCI,261200800001E-111-0-10,,DCTD Cancer Imaging,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$3,264,967"
Lung Cancer,2017,NCI,261200800001E-111-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,380,084"
Lung Cancer,2017,NCI,261201600007I-1-26100001-1,,"IGF::OT::IGF HHSN261201600007I/HHSN26100001, POP 03/01/2016 - 02/28/2017, PRIMARY PRODUCT/SERVICE CODE TO:  B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT","MATHEW, SUNITHA","WESTAT, INC.",MD,"$1,045,358"
Lung Cancer,2017,NCI,1K08CA222657-01,,New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss,"OSER, MATTHEW",DANA-FARBER CANCER INST,MA,"$177,120"
Lung Cancer,2017,NCI,3R01CA121249-08S1,,Cachexia in ApcMin/+ mice: The role of IL-6,"CARSON, JAMES",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$105,281"
Lung Cancer,2017,NCI,1F99CA223015-01,,Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer,"MOLLAOGLU, GURKAN",UNIVERSITY OF UTAH,UT,"$33,187"
Lung Cancer,2017,NCI,3R01CA172253-04S1,,Dissemination and implementation of a corrective intervention to improve mediasti,"OSAROGIAGBON, RAYMOND",UNIVERSITY OF MEMPHIS,TN,"$45,369"
Lung Cancer,2017,NCI,1R01CA215075-01A1,,Immune Regulation of Lung Squamous Metastasis,"PECOT, CHAD",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$400,580"
Lung Cancer,2017,NCI,1U54CA224065-01,8590,Research Project 1: PDX-based trials of precision medicine for treatment of KRAS mutant lung cancers,"FANG, BINGLIANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$551,800"
Lung Cancer,2017,NCI,1U54CA224081-01,8731,UCSF Project 1,"BIVONA, TREVER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$1,085,090"
Lung Cancer,2017,NCI,1U54CA224081-01,8732,Stanford Project 2,"KUO, CALVIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$1,091,369"
Lung Cancer,2017,NCI,3R43CA206682-01A1S1,,Mobile App for Behavioral Activation in Smoking Cessation with Elevated Depressive Symptom Smokers,"BROWN, RICHARD","HEALTH BEHAVIOR SOLUTIONS, INC.",TX,"$50,000"
Lung Cancer,2017,NCI,7R01CA140594-09,,Therapeutic strategies for specific subsets of KRAS mutant lung cancers,"WONG, KWOK KIN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$559,228"
Lung Cancer,2017,NCI,1K07CA214839-01A1,,Tobacco Treatment in the Context of Lung Cancer Screening,"ROJEWSKI, ALANA",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$179,784"
Lung Cancer,2017,NCI,1K07CA216330-01A1,,Development of a Novel Statewide Learning Collaborative to Increase Lung Cancer Guideline Adherence and Improve Cancer Care Delivery,"ODELL, DAVID",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$168,048"
Lung Cancer,2017,NCI,3R01CA131261-08S1,,Identifying the molecular mechanisms of the regulation of integrin B3 expression by the MAP Kinase pathway,"MCMAHON, MARTIN",UNIVERSITY OF UTAH,UT,"$50,494"
Lung Cancer,2017,NCI,3R01CA201124-02S1,,Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$189,200"
Lung Cancer,2017,NCI,3R01CA201340-02S1,,Defining Early Escape Strategies in LKB1 Mutant Lung Cancer S1,"MARCUS, ADAM",EMORY UNIVERSITY,GA,"$36,256"
Lung Cancer,2017,NCI,3P20CA202923-03S1,,Examining Chewing Tobacco Predictors and Perceived Cancer Risks among American Indians in the Cherokee Nation,"KHAN, SOHAIL",CHEROKEE NATION,OK,"$45,384"
Lung Cancer,2017,NCI,3P30CA138292-09S2,,Winship Cancer Institute Cancer Center Support Grant,"CURRAN, WALTER",EMORY UNIVERSITY,GA,"$102,081"
Lung Cancer,2017,NCI,1F31CA210619-01A1,,The Discovery and Optimization of Alternatives to ATP-Competitive ALK Inhibitors,"POWELL, CHELSEA",DANA-FARBER CANCER INST,MA,"$37,600"
Lung Cancer,2017,NCI,1F31CA224796-01,,Development of a novel platform for the identification of synthetic lethal genes in a Kras and Keap1-mutant mouse model of lung adenocarcinoma.,"ROMERO, RODRIGO",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$42,918"
Lung Cancer,2017,NHLBI,3R01HL116756-05S1,,Defining the role of Hippo signaling in airway injury repair and remodeling,"RAJAGOPAL, JAYARAJ",MASSACHUSETTS GENERAL HOSPITAL,MA,"$80,001"
Lung Cancer,2017,NIDA,1U01DA045523-01,,Biomarkers of exposure and effect in SREC users,"STEPANOV, IRINA",UNIVERSITY OF MINNESOTA,MN,"$580,975"
Lung Cancer,2017,NCI,3P30CA046934-29S1,,University of Colorado Cancer Center Support Grant,"THEODORESCU, DAN",UNIVERSITY OF COLORADO DENVER,CO,"$3,780"
Lung Cancer,2017,NCI,3R01CA190578-03S1,,Sox9 signaling in lung adenocarcinoma,"PINE, SHARON",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$40,000"
Lung Cancer,2017,NIDA,3R01DA037447-03S1,,Comparative Transcriptomic Signatures of Inhaled Tobacco Smoke,"MARIANI, THOMAS",UNIVERSITY OF ROCHESTER,NY,"$8,224"
Lung Cancer,2017,NCI,3R01CA150980-05S2,,Accountability for Cancer Care through Undoing Racism and Equity (ACCURE),"ENG, EUGENIA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$149,065"
Lung Cancer,2017,NCI,4R00CA197869-03,,Functional dissection of oncogenic enhancers,"HERRANZ BENITO, DANIEL",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$249,000"
Lung Cancer,2017,NCI,3R01CA205426-01A1S1,,Elucidating genetics of response to immune checkpoint blockade in lung cancer,"RIZVI, NAIYER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$159,998"
Lung Cancer,2017,NCI,3R01CA193220-03S1,,Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma,"BEVERLY, LEVI",UNIVERSITY OF LOUISVILLE,KY,"$51,321"
Lung Cancer,2017,NCI,7K99CA204593-02,,Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer,"ALTMAN, BRIAN",WISTAR INSTITUTE,PA,"$86,521"
Lung Cancer,2017,NCI,4R00CA187192-03,,Ultrasensitive Quantitation of Circulating Tumor DNA,"NEWMAN, AARON",STANFORD UNIVERSITY,CA,"$249,000"
Lung Cancer,2017,NIEHS,3R21ES025662-02S1,,RT-SQuARED-M method to study the precise role of mitochondria in the oxidative damage caused by environmental toxins,"MITRA, KASTURI",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$149,999"
Lung Cancer,2017,NCI,3R01CA184987-04S2,,Interactions between tobacco smoke constituents in rodent tumor models,"PETERSON, LISA",UNIVERSITY OF MINNESOTA,MN,"$25,000"
Lung Cancer,2017,NCI,4R00CA197672-03,,Manipulating hTERT splicing in lung cancer cells.,"LUDLOW, ANDREW",UNIVERSITY OF MICHIGAN,MI,"$249,210"
Lung Cancer,2017,NCI,261201500003I-2-26100025-1,,Lung Cancer Multiple Reaction Monitoring Project,"BOCIK, WILLIAM","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$3,187,530"
Lung Cancer,2017,NCI,4R00CA187317-03,,Investigating cellular heterogeneity in lung cancer,"TAMMELA, TUOMAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$249,000"
Lung Cancer,2017,NCI,3P30CA012197-42S2,,Cancer Center Support Grant,"PASCHE, BORIS",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$74,986"
Lung Cancer,2017,NIEHS,7R01ES026171-02,,"A cohort study of air pollution, lung cancer, and COPD in Los Angeles County","CHENG, IONA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$635,786"
Lung Cancer,2017,NCI,3R01CA166480-06S1,,MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer,"KUFE, DONALD",DANA-FARBER CANCER INST,MA,"$126,024"
Lung Cancer,2017,NCI,4R44CA203068-02,,PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.,"BERTENSHAW, GREG","BIOMARKER STRATEGIES, LLC",MD,"$988,207"
Lung Cancer,2017,NCI,7R01CA197398-03,,Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer,"MACKEIGAN, JEFFREY",MICHIGAN STATE UNIVERSITY,MI,"$484,156"
Lung Cancer,2017,NCI,261201300008I-2-26100010-1,,SUPPORT SERVICES FOR THE PLCO ETIOLOGIC & EARLY MARKER STUDIES(PLCO EEMS),"RILEY, TOM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$894,589"
Lung Cancer,2017,NCI,1ZIACP000176-13,,Biologic Specimen Bank for Early Lung Cancer Markers,"ABNET, CHRISTIAN",NIH,,"$347,968"
Lung Cancer,2017,NCI,1ZIACP000185-13,,Upper Gastrointestinal Cancer Studies,"DAWSEY, SANFORD",NIH,,"$2,012,481"
Lung Cancer,2017,NCI,1ZIACP005804-23,,Pharmacogenetic Studies,"CAPORASO, NEIL",NIH,,"$407,387"
Lung Cancer,2017,NCI,1ZIACP010120-22,,Studies of Occupational Cancer,"LAN, QING",NIH,,"$2,973,053"
Lung Cancer,2017,NCI,1ZIACP010123-22,,Occupational and Environmental Determinants of Cancer among Women and Minorities,"BEANE FREEMAN, LAURA",NIH,,"$352,884"
Lung Cancer,2017,NCI,1ZIACP010125-22,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,463,246"
Lung Cancer,2017,NCI,1ZIACP010127-22,,Etiologic Studies of Diet and Cancer,"FREEDMAN, NEAL",NIH,,"$278,690"
Lung Cancer,2017,NCI,1ZIACP010134-22,,Studies of Atomic Bomb Survivors,"MABUCHI, KIYOHIKO",NIH,,"$132,868"
Lung Cancer,2017,NCI,1ZIACP010135-22,,Studies of Non-Ionizing Radiation-Related Cancer,"FREEDMAN, DARYL",NIH,,"$584,244"
Lung Cancer,2017,NCI,1ZIACP010136-22,,Cancer Risk in Human Populations,"SILVERMAN, DEBRA",NIH,,"$2,956,825"
Lung Cancer,2017,NCI,1ZIACP010144-19,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"PEMOV, ALEXANDER",NIH,,"$9,903,769"
Lung Cancer,2017,NCI,1ZIACP010152-18,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$736,077"
Lung Cancer,2017,NCI,1ZIACP010169-16,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$356,089"
Lung Cancer,2017,NCI,1ZIACP010183-15,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$725,750"
Lung Cancer,2017,NCI,1ZIACP010184-15,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$910,442"
Lung Cancer,2017,NCI,1ZIACP010187-13,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$106,767"
Lung Cancer,2017,NCI,1ZIACP010188-13,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$860,562"
Lung Cancer,2017,NCI,1ZIACP010195-11,,"Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","ABNET, CHRISTIAN",NIH,,"$2,038,418"
Lung Cancer,2017,NCI,1ZIACP010200-10,,GEI - Genome-Wide Association Studies,"CAPORASO, NEIL",NIH,,"$162,269"
Lung Cancer,2017,NCI,1ZIACP010207-08,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$800,895"
Lung Cancer,2017,NIEHS,1ZIAES049033-21,,Genetic Susceptibility And The Environment In Cancer Risk,"TAYLOR, JACK",NIH,,"$316,807"
Lung Cancer,2017,NIEHS,1ZIAES046008-27,,Genetic Susceptibility To Carcinogens,"BELL, DOUGLAS",NIH,,"$729,214"
Lung Cancer,2017,NCI,3U01CA196405-04S1,,"Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma","MASSION, PIERRE",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$316,000"
Lung Cancer,2017,NCI,3U01CA196408-03S1,,"Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer","DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$456,656"
Lung Cancer,2017,NHLBI,1ZIAHL000659-25,,ADP-ribosylation Cycles,"MOSS, JOEL",NIH,,"$1,136,382"
Lung Cancer,2017,NCI,261201200035I-2-26100004-1,,PROTOCOL NWU2013-02-01A PHASE I TRIAL OF INHALED ILOPROST FOR THE PREVENTION OF LUNG CANCER IN FORMER SMOKERS,"BERGAN, RAYMOND",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$461,777"
Lung Cancer,2017,NCI,ACN15006001-1-0-1,,NCI Early Detection Research Network:  Biomarker Reference and Resource Center (BRRC),NO PI IDENTIFIED,NIH,,"$800,000"
Lung Cancer,2017,NCI,1ZIABC005177-37,,Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,"POIRIER, MIRIAM",NIH,,"$59,366"
Lung Cancer,2017,NCI,1ZIABC006161-34,,DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,"POMMIER, YVES",NIH,,"$1,021,151"
Lung Cancer,2017,NCI,1ZIABC010298-20,,Growth Regulation Section,"PASTAN, IRA",NIH,,"$427,052"
Lung Cancer,2017,NCI,1ZIABC010440-16,,"Protein Structure, Stability, and Amyloid Formation","NUSSINOV, RUTH",NIH,,"$757,547"
Lung Cancer,2017,NCI,1ZIABC010449-16,,Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,"KIMURA, SHIOKO",NIH,,"$538,486"
Lung Cancer,2017,NCI,1ZIABC010661-13,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$648,692"
Lung Cancer,2017,NCI,1ZIABC010816-11,,"Immunotherapy for  Malignant Mesothelioma, Lung Cancer and Thymic Malignancies","HASSAN, RAFFIT",NIH,,"$849,274"
Lung Cancer,2017,NCI,1ZIABC010853-11,,Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"KLINMAN, DENNIS",NIH,,"$345,778"
Lung Cancer,2017,NCI,1ZIABC011115-10,,Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,"SCHRUMP, DAVID",NIH,,"$1,353,606"
Lung Cancer,2017,NCI,1ZIABC011124-10,,Oncogenic Met Signaling in Urologic Malignancies,"BOTTARO, DONALD",NIH,,"$496,098"
Lung Cancer,2017,NCI,1ZIABC011204-09,,Preclinical development of TIMP-2 as a biologic therapy for cancer,"STETLER-STEVENSON, WILLIAM",NIH,,"$936,906"
Lung Cancer,2017,NCI,1ZIABC011332-08,,Tumor Microenvironment in Cancer Progression,"KAPLAN, ROSANDRA",NIH,,"$661,011"
Lung Cancer,2017,NCI,1ZIABC011391-07,,Role of IKK alpha in lung cancer development,"HU, YINLING",NIH,,"$497,920"
Lung Cancer,2017,NCI,1ZIABC011408-07,,Comparison of substrate specificities of wild type and mutant EGFR kinases,"GUHA, UDAYAN",NIH,,"$39,004"
Lung Cancer,2017,NCI,1ZIABC011410-07,,Protein phosphorylation downstream of mutant EGFR kinases,"GUHA, UDAYAN",NIH,,"$838,579"
Lung Cancer,2017,NCI,1ZIABC011412-07,,Role of MIG6 in mutant EGFR-driven lung tumorigenesis,"GUHA, UDAYAN",NIH,,"$97,509"
Lung Cancer,2017,NCI,1ZIABC011414-07,,Identification of potentially active tyrosine kinases in lung cancer,"GUHA, UDAYAN",NIH,,"$97,509"
Lung Cancer,2017,NCI,1ZIABC011418-07,,Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,"SCHRUMP, DAVID",NIH,,"$773,489"
Lung Cancer,2017,NCI,1ZIABC011492-05,,"Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome","HARRIS, CURTIS",NIH,,"$1,150,123"
Lung Cancer,2017,NCI,1ZIABC011495-05,,Integrative Molecular Epidemiology of Human Cancer,"HARRIS, CURTIS",NIH,,"$1,150,123"
Lung Cancer,2017,NCI,1ZIABC011524-05,,Mechanical regulation of the microenvironmental niche in skin tumorigenesis,"TANNER, KANDICE",NIH,,"$311,502"
Lung Cancer,2017,NCI,1ZIABC011529-05,,In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,"GUHA, UDAYAN",NIH,,"$390,036"
Lung Cancer,2017,NCI,1ZIABC011554-04,,Lung Cancer Health Disparities,"RYAN, BRID",NIH,,"$901,339"
Lung Cancer,2017,NCI,1ZIABC011555-04,,Gene-Environment Interactions in Lung Cancer,"RYAN, BRID",NIH,,"$386,288"
Lung Cancer,2017,NCI,1ZIABC011651-03,,Laboratory and Clinical studies on T-cells recognizing NSCLC,"YANG, JAMES",NIH,,"$404,359"
Lung Cancer,2017,NCI,1ZIABC011657-03,,microRNA regulatory networks in thoracic cancers,"HOANG, CHUONG",NIH,,"$1,028,085"
Lung Cancer,2017,NCI,1ZIABC011672-02,,Clinical Protocols in the Cancer Signaling Networks Section,"GUHA, UDAYAN",NIH,,"$487,546"
Lung Cancer,2017,NCI,1ZIABC011691-02,,Oncogenic Kinases in Cancer,"BROGNARD, JOHN",NIH,,"$1,099,330"
Lung Cancer,2017,NCI,1ZIABC011700-02,,Patient Oriented Research in Viral Malignancies and HIV-associated Cancers,"YARCHOAN, ROBERT",NIH,,"$77,563"
Lung Cancer,2017,NCI,1ZIABC011736-02,,Preclinical Development of Therapeutics in Murine Models of Lung Cancer,"SHARAN, SHYAM",NIH,,"$513,288"
Lung Cancer,2017,NCI,1ZIABC011744-01,,Kinase complexes in human diseases,"ZHANG, PING",NIH,,"$1,287,210"
Lung Cancer,2017,NCI,1ZIABC011787-01,,Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer,"CHEN, HAOBIN",NIH,,"$341,450"
Lung Cancer,2017,NCI,1ZIASC010093-21,,Epigenetic Therapy for Thoracic Malignanceis,"SCHRUMP, DAVID",NIH,,"$386,745"
Lung Cancer,2017,NCI,1ZICBC010937-10,,Novel Targets for Vaccine Therapy,"PALENA, CLAUDIA",NIH,,"$714,123"
Lung Cancer,2017,NCI,1ZICBC010953-10,,Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"SIMPSON, ROBERT",NIH,,"$866,362"
Lung Cancer,2017,NCI,1ZIDBC011540-04,,Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,"HASSAN, RAFFIT",NIH,,"$1,890,317"
Lung Cancer,2017,NCI,1ZIDBC011541-04,,TGIB Surgical Consultative Services,"SCHRUMP, DAVID",NIH,,"$2,578,296"
Lung Cancer,2017,NCI,1ZIDBC011792-01,,Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,"PACK, SVETLANA",NIH,,"$582,570"
Lung Cancer,2017,NCI,1ZIGBC011735-02,,Development of Novel Preclinical Animal Models - CAPR Infrastructure,"SHARAN, SHYAM",NIH,,"$513,288"
Lung Cancer,2017,NCI,3U01CA196386-03S1,,Coordinating Center:  Molecular and Cellular Findings of Screen-Detected Lesions,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,NH,"$559,564"
Lung Cancer,2017,NCI,3P30CA046934-29S2,,University of Colorado Cancer Center Support Grant,"THEODORESCU, DAN",UNIVERSITY OF COLORADO DENVER,CO,"$104,106"
Lung Cancer,2017,NCI,3P30CA016520-41S2,,Abramson Cancer Center Support Grant,"VONDERHEIDE, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$62,491"
Lung Cancer,2017,NIAID,1ZIAAI000725-20,,Activities Of Chemokines In Health and Disease,"FARBER, JOSHUA",NIH,,"$1,631,747"
Lung Cancer,2017,NCI,3P30CA023108-38S4,5366,Cancer Control (CC),"SARGENT, JAMES",DARTMOUTH COLLEGE,NH,"$1,127"
Lung Cancer,2017,NCI,261201500032I-1-26100002-1,,TARGETING THE IL SIGNAL PATHWAY,"MENGES, CRAIG",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$350,383"
Lung Cancer,2017,NCI,3P30CA168524-06S1,8710,Clinical Pharmacology Shared Resource,"REED, GREGORY",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$12,826"
Lung Cancer,2017,NEI,263201300005C-10-0-1,,Age Related Eye Disease Study 2 - Follow-on Study,"CLEMONS, TRACI",EMMES CORPORATION,MD,"$256,644"
Lung Cancer,2017,OD,263201300005C-10-0-1,,Age Related Eye Disease Study 2 - Follow-on Study,"CLEMONS, TRACI",EMMES CORPORATION,MD,"$100,000"
Lung Cancer,2017,NHGRI,1ZIAHG200331-13,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$780,567"
Lung Cancer,2017,NCI,261201700017C-0-0-1,,IGF::OT::IGF SBIR TOPIC 355: Cell and Animal-Based Models to Advance Cancer Health Disparity Research. To contribute to studies of cancer health disparities by generating several patient-derived xenog,"YESHI, TSETEN","HERA TESTING LABORATORIES, INC.",KY,"$293,728"
Lung Cancer,2017,NCI,261201700024C-0-0-1,,IGF::OT::IGF SBIR Phase II Topic 357; POP: 09/12/2017 - 09/11/2019,"MARKO, AIMEE","PHOTOLITEC, LLC",NY,"$1,908,933"
Lung Cancer,2017,NCI,261201600012I-0-26100002-1,,TSS CPTAC Digital Medical Images of CPTAC Biospecimens,"GASPARIAN, ALEXANDER",NIH,CA,"$66,300"
Lung Cancer,2017,NCI,261201600005I-0-26100002-1,,"Medical Images for BiospecimensThe Task Order is in the amount of $71,250.00","WIZNEROWICZ, MACIEJ",INTERNAT'L INSTITUTE/MOLECULAR ONCOLOGY,POLAND,"$71,250"
Lung Cancer,2017,NCI,261201200042I-0-26100013-1,,IGF::OT::IGF A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER,"LIMBURG, PAUL",MAYO CLINIC ROCHESTER,MN,"$390,096"
Lung Cancer,2017,NCI,261201200031I-0-26100012-1,,IGF::OT::IGF Clinical Study of Avmacol for Detoxification of Tobacco Carcinogens in Heavy Smokers,"CHOW, SHERRY",UNIVERSITY OF ARIZONA,AZ,"$487,895"
Lung Cancer,2017,NCI,261201700034C-0-0-1,,IGF::OT::IGF SBIR Phase II: Topic 338 - Defining Normal Tissue and Tumor Biomarkers of Radiosensitivity to Best Direct Treatment,"SALZMAN, DAVID","MIRA DX, INC.",CA,"$1,999,999"
Lung Cancer,2017,NCI,261201500024I-0-26100004-1,,IGF::OT::IGF Support for the Aerosol Development of Bexarotene HHSN2612015000240 TO: HHSN26100004 PoP: 9/18/2017 to 9/17/2019,"MCCORMACK, DAVID",IIT RESEARCH INSTITUTE,IL,"$2,597,086"
